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“That which besets me is indifference. I can't be bothered about people. Or rather, won't.  
For I avoid, carefully, all occasions for being bothered... Indifference is a form of sloth,  
and sloth in its turn is one of the symptoms of lovelessness.  
One isn't lazy about what one loves. The problem is: how to love?” 
- Aldous Huxley, Eyeless in Gaza 
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ABSTRACT 
Alexithymia is a personality construct first identified in hospitalized psychosomatic 
patients. It is characterized by difficulties in identifying (DIF) and describing (DDF) 
feelings, an externally oriented, or concrete and pragmatic thinking style (EOT), as 
well as a scarcity of fantasy and imagination. Alexithymia has been associated with 
increased psychiatric and somatic morbidity across diagnostic categories, as well as 
increased markers of physiological stress. The etiology of alexithymia is unclear 
although childhood environmental influences are likely to play a role in it. Several 
studies imply that alexithymia is a heterogeneous phenomenon with possible subtypes 
that have differential associations with mental health and emotion regulation. 
This dissertation is part of the FinnBrain Birth Cohort Study, in which we 
analyzed a large sample of fathers and mothers and compared their alexithymic traits 
with mental and physical health outcomes, as well as self-reported early-life 
adversities in childhood. 
Our results support the hypotheses of the existence of two alexithymia subtypes: 
One characterized by high levels of DIF, as well as increased depressive and anxiety 
symptoms; and another characterized by high levels of EOT, exhibiting lower 
psychiatric symptomatology. However, EOT, even while not increasing the risk for 
mood or anxiety symptoms, was associated with increased substance use in men, and 
a higher BMI and higher prevalence of gestational diabetes in women. In pregnant 
women, alexithymic traits, and especially the dimension of DIF, was additionally 
associated with higher hair cortisol concentrations during late pregnancy, indicating 
heightened levels of chronic stress. Regarding early-life adversity, we showed that 
alexithymia was specifically related to childhood experiences of emotional neglect 
and was associated with adult attachment insecurity. 
These findings show that alexithymic traits have differential associations with 
psychiatric symptomatology, substance use and metabolic health. Importantly, they 
show that many of these associations are independent of mood and anxiety. Findings 
on early-life adversity in alexithymia imply that depression with concurrent 
alexithymia may represent a specific subtype of depression, treatment of which may 
benefit from a focus on childhood emotional neglect and attachment insecurity. 
KEYWORDS: Alexithymia, Psychosomatic, Early-life adversity, Depression, 
Anxiety, Childhood Maltreatment, Chronic Stress, Cortisol  
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TIIVISTELMÄ 
Aleksitymia kuvaa moniulotteista persoonallisuuden piirteistöä, jonka tunnus-
merkkejä ovat vaikeudet tunteiden tunnistamisessa ja ilmaisussa, mielikuvituksen 
köyhyys sekä ulkokohtainen ajattelutyyli, jossa kiinnostus sisäiseen maailmaan ja 
tunteisiin on vähäistä. Aleksitymia on liitetty moniin somaattisiin ja psyykkisiin 
terveysongelmiin, sekä fysiologiseen stressiin. Useat tutkimukset viittaavat siihen, 
että aleksitymiaa ei voida pitää yksiulotteisena ilmiönä, vaan sillä on useita 
alatyyppejä, joilla saattaa olla erilaisia vaikutuksia terveyteen ja tunnesäätelyyn.  
Aleksitymian syntymekanismit ovat edelleen epäselviä, mutta lapsuuden 
ympäristöllä ja vastoinkäymisillä ajatellaan olevan merkittävä rooli sen kehitty-
misessä.  
Tämä tutkimus on osa FinnBrain syntymäkohorttitutkimusta. Tutkimusaineisto 
koostuu suuresta otoksesta isiä ja äitejä. Tutkimme tässä populaatiossa aleksityy-
misten piirteiden yhteyttä fyysiseen terveyteen, mielenterveyteen sekä lapsuuden 
vastoinkäymisiin. 
Löydöksemme tukevat hypoteeseja aleksitymian kahdesta alatyypistä: Ensim-
mäistä alatyyppiä luonnehtivat subjektiivinen vaikeus tunnistaa ja ilmaista tunteita, 
sekä lisääntynyt masennus- ja ahdistuneisuusoireisto. Toisessa alatyypissä 
korostuneempana on ulkokohtainen ajattelutyyli, eikä siihen liity lisääntynyttä 
psykiatrista oireilua. Ulkokohtainen ajattelutyyli kuitenkin lisäsi alkoholin ja 
tupakan kulutusta miehillä, sekä oli yhteydessä ylipainoon ja raskausdiabetekseen 
naisilla, riippumatta samanaikaisista masennus- ja ahdistusoireista. Raskaana ole-
villa naisilla aleksitymia oli lisäksi yhteydessä korkeampiin hiusten kortisolitasoihin, 
mikä viittaa krooniseen stressiin. Lapsuuden vastoinkäymisten osalta löydöksemme 
viittaavat siihen, että aleksitymia on yhteydessä lapsuuden emotionaaliseen vaille 
jäämiseen sekä kiintymyssuhdeongelmiin. 
Löydökset korostavat aleksitymian monimuotoisuutta, ja osoittavat, että 
aleksitymian eri ulottuvuudet ovat yhteydessä erilaisiin terveysongelmiin sekä 
päihteidenkäyttöön. Nämä yhteydet ovat lisäksi riippumattomia samanaikaisista 
masennus- ja ahdistuneisuusoireista. Löydökset liittyen lapsuuden vastoinkäymisiin 
aleksitymian taustalla korostavat emotionaalisen vaille jäämisen ja kiintymys-
suhdeongelmien tärkeyttä, ja voivat auttaa uusien hoitomuotojen kehittämisessä 
psykiatrisille potilaille, joilla on aleksityymisiä piirteitä.  
AVAINSANAT: Aleksitymia, psykosomatiikka, lapsuuden vastoinkäymiset, 
masennus, ahdistuneisuus, lapsuuden kaltoinkohtelu, krooninen stressi, kortisoli  
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1 Introduction 
Alexithymia is a personality construct characterized by difficulties in identifying and 
verbalizing emotions, a restricted capacity for imagination and fantasy, as well as an 
externally oriented thinking style, referring to a pragmatic way of thinking, lacking 
interest in emotional experience and introspection (Sifneos 1973). Individuals high 
in alexithymic traits exhibit deficiencies in emotional awareness, emotion regulation 
and interpersonal communication and thus, lack the capacity to reflect on their inner 
experience (Lumley, Neely & Burger 2007). For this reason, alexithymia has been 
seen as a hindrance to psychoanalytic and psychotherapeutic treatment (Bagby & 
Taylor 1997a). Indeed, alexithymia has been associated with poorer treatment 
responses not only to psychotherapy, but also to psychopharmacological treatment 
of mental health disorders (Ozsahin et al. 2003; Lumley, Neely & Burger 2007). 
Alexithymia has been linked to a myriad of mental and physical health problems 
such as Major Depression, anxiety disorders, eating disorders, somatization, 
substance abuse, pain disorders, autoimmune disease and cardiovascular disease 
(Fernandez et al. 1989; Honkalampi et al. 2000a; Marchesi et al. 2005; Mattila et al. 
2008; Thorberg et al. 2009; Grabe et al. 2010; Tolmunen et al. 2010; Nowakowski 
et al. 2013; Montoro et al. 2016; Chalah & Ayache 2017). It is commonly believed 
that alexithymia is a fixed personality trait that constitutes a risk factor for mental 
and physical illness (e.g. Karukivi et al. 2014a). However, empirical evidence 
regarding this view is not established, and other researchers have proposed that the 
alexithymia construct may simply be a marker of negative affect in depressed or 
anxious individuals, not a vulnerability factor in itself (e.g. Marchesi et al. 2014). As 
most alexithymia studies have been cross-sectional, this question of causality is still 
not fully resolved, but research seems to support the view that alexithymia is a 
relatively stable trait that can be slightly affected by changes in mood (Picardi et al. 
2005; Saarijärvi et al. 2006; Hiirola et al. 2017).  
The link between alexithymia and mental/physical illness could be explained by 
several factors. Alexithymic individuals are more often unmarried, and have a lower 
education level and income, all representing risk factors for impaired health 
outcomes (Mattila 2008). Some evidence suggests that alexithymia is related to 
impaired emotional awareness and emotion regulation (da Silva et al. 2017; Swart et 
Jani Kajanoja 
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al. 2009), as well as problems in the interpersonal domain (Spitzer et al. 2005). These 
in turn could lead to chronically heightened levels of physiological stress, and thus, 
ultimately, to many stress-related mental and somatic health problems. This is known 
as the alexithymia-stress -hypothesis (Martin & Pihl 1985). Another possible 
pathway for impaired health in alexithymia lies in lifestyle factors and unhealthy 
behaviors. Alexithymic individuals seem to differ both in dietary and substance use 
patterns compared to non-alexithymic controls. Specifically, they are more prone to 
emotional eating and using substances to regulate stressful emotions (Lumley et al. 
1996; Thorberg et al. 2009; Honkalampi et al. 2017; Lyvers et al. 2019; Pink et al. 
2019). All of these risk factors ─ Low socioeconomic status, interpersonal problems, 
chronic stress and unhealthy behaviors ─ commonly overlap, and likely causally 
affect each other. 
The etiology of alexithymia is largely unclear. Childhood experiences and 
quality of parenting are likely to play a significant role in the development of 
alexithymic features (Karukivi & Saarijärvi 2014). Alexithymia has been associated 
with childhood emotional neglect and inadequate maternal care (Aust et al. 2013; 
Thorberg et al. 2011). Genetic and twin studies indicate that alexithymia also has a 
heritable component (Jørgensen et al. 2007; Terock et al. 2018). Regarding the 
etiology of alexithymia, it is important to understand that alexithymic individuals are 
a heterogenous group, and the individual dimensions of alexithymia are differentially 
associated with mental health and emotional processing (Grabe et al. 2004). 
Therefore, some researchers have proposed the existence of alexithymia subtypes 
(Bagby et al. 2009; Chen et al. 2011) that could also differ in terms of etiology. 
The nature of alexithymia as a distinct phenomenon or personality trait is still 
under debate, and so is its relevance as a risk factor for mental health problems. 
Therefore, it is important to carefully characterize alexithymic individuals and their 
health status, also using biological markers, controlling for concurrent 
psychopathology. The aims of this thesis were three-fold: Firstly, to characterize 
possible subtypes of alexithymia, and examine how the individual dimensions of 
alexithymia relate to mental and physical health status, as well as substance use. 
Secondly, to study the association of alexithymia and physiological stress, using hair 
cortisol concentrations as a biological marker of chronic stress. Thirdly, to elucidate 
the etiology of alexithymia by examining its associations with early-life adversity 
and adult attachment security. 
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2 Review of the Literature 
2.1 On Psyche and Soma 
As this dissertation concerns problems in emotional awareness and emotional 
processing, it seems appropriate to begin by attempting to define emotion. Despite 
millennia of philosophical inquiry and empirical research, we still lack a definitive 
description of what an emotion actually is and what its relationship is with other 
cognitive faculties. The Greeks and Romans saw emotions as “pertubationes animi”, 
as disturbances hindering reason. If science has yet to elucidate the nature of 
emotion, what we do know nowadays is that they serve much more vital functions 
and cannot be regarded as simply inferior to cognition and rationality: The 
experience of emotion is central to human life and interpersonal functioning. In order 
to survive we need to steer attention towards both pleasurable/appetitive, as well as 
dangerous/threatening stimuli. We also derive our quality of life and sense of 
meaning and fulfillment from emotions. Moreover, negative affect and anhedonia — 
the inability to feel pleasure — are core features of most psychiatric disorders. One 
comprehensive definition of emotion describes it as a feeling state/process that 
motivates and organizes cognition and action (Izard 2010). In other words, emotion 
could be considered as a mental process that coordinates approach and avoidance 
behavior as a response to environmental stimuli. However, even this description is 
not exhaustive, and many researchers have questioned whether the term emotion 
actually represents any ‘real’ biological category (Feldman Barrett 2006; 
Kringelbach & Phillips 2014).  
The idea that the psyche (mind) could affect the soma (body) and its health has 
been around for a long time. In ancient Greece, Socrates deemed physicians too 
somatically oriented, and emphasized that the body cannot be cured without 
addressing the mind (Raginsky 1948). Galen was one of the first physicians to 
advocate the view that ‘passions’ could both cause and cure diseases. Many medieval 
physicians and philosophers subscribed to this view and further developed them 
(Ackerknecht 1982). However, until the 19th century, the link between emotions and 
physical health was mostly based on opinions and anecdotes. In the 19th and early 
20th centuries, the works of William James, Ivan Pavlov and Walter Cannon among 
others initiated empirical investigations into the physiological basis of emotions. 
Jani Kajanoja 
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Interest in the psyche as an etiological factor in physical disease was further ignited 
by the rise of psychoanalysis (Lipowski 1982). Franz Alexander, an early 
psychoanalyst considered one of the founders of modern psychosomatic medicine, 
formulated a more detailed account of mental conflicts inducing physical disease 
(Lipowski 1982). He suggested that conflicts between unconscious drives and the 
ego or superego could create chronic tension, ultimately manifesting as dysfunction 
in specific organs (Lipowski 1982). These ideas set the stage for the emergence of 
psychosomatic medicine, which became a separate medical field in the 20th century, 
founded on the presumption that personality features and emotions can affect the 
onset and development of physical disease. 
2.2 History of the Alexithymia Construct 
Alexithymia, literally translating ‘no words for mood’, is defined as a difficulty in 
identifying and verbalizing feelings in the self, an externally oriented thinking style, 
as well as a scarcity of imagination and fantasy. Alexithymia was first 
conceptualized by Peter Sifneos in 1973 (Sifneos 1973). Psychoanalysts in the 1940s 
and 1950s had noticed that many patients with unexplained somatic symptoms, were 
unimaginative, lacking introspection and showing remarkable difficulties in 
verbalizing their emotions (Taylor 1984). These patients were considered difficult to 
treat by psychoanalytic methods, as they lacked introspective tendencies, showed 
disinterest in dreams and fantasies, and showed a pragmatic, externalizing cognitive 
style. They also engaged in substance abuse, aberrant eating behaviors and 
compulsions, seemingly to avoid negative emotions (Taylor 1984). Early 
psychoanalysts emphasized the role of intrapsychic conflict in psychosomatic 
diseases. Unconscious conflicts were seen to cause chronic emotional arousal, 
leading to physiological changes and disease (Lesser 1981). Subsequently, this 
conflict-based theory started to lose support as it was apparent that psychoanalytic 
treatment did not produce expected results (Lesser 1981; Taylor 1991). 
The physician and neuroscientist Paul MacLean, who put forward the concept of 
the triune brain, had also noticed this tendency of diminished emotional expression 
in psychosomatic patients. He speculated that in these patients, the neocortex fails to 
symbolically process emotional information, and instead it finds an outlet through 
the autonomic nervous system, resulting in harmful physiological changes and 
possibly leading to disease (MacLean 1949). Nemiah and Sifneos were the first to 
conduct a systematic study of the personality features and cognitive style of 
psychosomatic patients, and their results seemed to confirm psychoanalysts’ 
intuitions. Sifneos reported that psychosomatic patients were characterized by 
difficulties in identifying and verbalizing emotions, an externally oriented, 
pragmatic thinking style, as well as a paucity in imagination and fantasy. He termed 
Review of the Literature 
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this constellation of features ‘alexithymia’ and developed the Beth Israel Hospital 
Psychosomatic Questionnaire to assess them (Sifneos 1973). At the same time, 
similar features were being described by other researchers in patient populations 
suffering from post-traumatic stress-disorder and substance abuse (Bagby & Taylor 
1997a). 
Instead of intrapsychic conflicts, theories of alexithymia focused on the 
differentiation of emotional experience, and emotion regulation. The lack of ability 
to accurately identify emotions, is thought to obstruct their expression and therefore 
also the regulation of emotion by interpersonal communication. Furthermore, 
lacking imagination and insight into their own emotional world, alexithymic 
individuals have difficulties in putting themselves in other people’s situation and 
mental states, thus hindering their empathic abilities (Bagby & Taylor 1997a). 
Martin and Pihl (1985) later refined the theory on alexithymia and stress, suggesting 
that the link between alexithymic features and somatic symptoms would arise from 
an inability to consciously process emotional information. This inability was thought 
to lead to an excessive focus on physical sensations accompanying emotion. This 
was thought to explain the tendencies for hypochondria and somatization, as well as 
emotion regulation strategies through compulsive behaviors. This failure to process 
and regulate emotion consciously, was also hypothesized to amplify the 
physiological responses to stressful events and negative emotions, ultimately leading 
to physical illness (Martin & Pihl 1985; Taylor 1991). 
Alexithymia was the main theme in the 1976 European Conference of 
Psychosomatic Research in Heidelberg. Here, a consensus on the concept of 
alexithymia was achieved, and agreed that further research validating the construct, 
and development of reliable measures were needed (Bagby & Taylor 1997a). 
Subsequently, alexithymia research gradually moved from concerning only the field 
of psychosomatics, to more broadly studying the effects of affects, emotion 
regulation and personality in health and sickness (Mattila 2008). 
2.3 Measuring Alexithymia 
In a clinical setting, the most common approach to assess alexithymia is clinical 
judgement based on interviews. However, as this approach is not psychometrically 
reliable, other ways of measuring alexithymia had to be developed for the purposes 
of advancing research (Lumley et al 2007). Sifneos (1973) in his original article 
where he coined the term alexithymia, introduced the Beth-Israel Hospital 
Psychosomatic Questionnaire. It is a 17-item, forced choice questionnaire that the 
interviewer fills after an unstructured conversation with the patient. The purpose of 
the unstructured conversation is to probe the patient’s ability to describe emotions, 
fantasy and dreams. Some support for the validity and factor structure of this 
Jani Kajanoja 
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questionnaire has been obtained, but its inter-rater reliability has been shown to be 
questionable (Bagby & Taylor 1997b). Since the release of the Beth-Israel Hospital 
Psychosomatic Questionnaire, several validated measures have been developed to 
assess alexithymia. These include questionnaires and structured interviews, as well 
as projective tests and speech content analyses (Taylor 1984).  
The Schalling-Sifneos Personality Scale (SSPS) (Apfel & Sifneos 1979) was the 
first attempt to create a standardized self-report questionnaire to assess alexithymia. 
It was used in the Beth-Israel Hospital. Around the same time, Kleiger & Kinsman 
(1980) created the MMPI alexithymia scale, based on correlations between the Beth-
Israel Hospital Psychosomatic Questionnaire and items inthe Minnesota Multiphasic 
Personality Inventory. The MMPI alexithymia scale was widely used for a period of 
time, but its validity was later questioned (Federman & Mohns 1984; Bagby et al. 
1988). Bagby et al. (1988), in their validity study comparing the MMPI and SSPS 
with the Toronto Alexithymia Scale (introduced below), found that both the SSPS 
and MMPI showed “response and/or gender biases, poor internal reliabilities, and no 
systematic relationship with somatic symptoms”. 
A few years later, Taylor et al. (1985) developed the Toronto Alexithymia Scale 
(TAS).  This self-report questionnaire initially contained 26 items measured on a 5-
point Likert scale. They included four dimensions: Difficulty Identifying Feelings 
(DIF), Difficulty Describing Feelings (DDF), reduced daydreaming, and an 
Externally Oriented Thinking style (EOT). The TAS-26 was later refined, and the 
dimension of reduced daydreaming was dropped out. In 1994, the authors introduced 
the 20-item TAS with three dimensions measuring DIF, DDF and EOT (TAS-20). 
The TAS-20 has been by far the most widely used self-report questionnaire in 
alexithymia studies and has repeatedly shown good validity and reliability (Bagby 
et al. 1994a; Joukamaa et al. 2001; Taylor et al. 2003). However, it does have some 
drawbacks. The TAS-20 does not measure lack of imagination, an essential part of 
the original alexithymia construct. Furthermore, the EOT dimension of the TAS has 
been found in some studies to have poor internal consistency (Kooiman et al. 2002, 
Müller et al. 2003). 
The Bermond-Vorst Alexithymia Questionnaire (BVAQ) was developed later in 
the 1990s (Vorst & Bermond 2001). This questionnaire is divided into affective and 
cognitive components, measuring emotionalizing and fantasizing (affective), and 
identifying, describing, and analyzing feelings (cognitive). Emotionalizing here 
refers to the capacity to be emotionally aroused by emotion-evoking stimuli. The 
BVAQ has shown good psychometric quality in several studies (Vorst & Bermond 
2001; Deborde et al. 2008; Vroege et al. 2018). However, emotionalizing was not 
part of the original alexithymia construct, and recent studies using both network 
analysis and factor analysis, do not support the inclusion of emotionalizing and 
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fantasizing as salient features of the alexithymia construct (Watters et al. 2016; 
Preece et al. 2017). 
Recently, Preece et al. (2017) examined the theoretical components of the 
alexithymia construct via confirmatory factor analysis, using both TAS-20 and 
BVAQ as alexithymia measures. They concluded that previous literature, as well as 
their own findings, support the view that alexithymia consists of only three 
dimensions: DIF, DDF and EOT. Furthermore, they made an attempt to integrate the 
alexithymia construct into the wider theory of emotion regulation by James Gross 
(Gross 2015) and argued that DIF and DDF could be considered deficits in the 
accurate appraisal of emotional information, while EOT depicts inattention or 
disinterest concerning emotions and the inner world. They called this the attention-
appraisal -model of alexithymia and developed the Perth Alexithymia Questionnaire, 
which focuses on the subjective capacity to accurately differentiate emotions across 
valences, and the tendency to pay attention to and be interested in emotions (Preece 
et al. 2018).  
Structured interviews for assessing alexithymia include the modified version of 
the BIQ described above (Bagby et al. 1994b), the Alexithymia Provoked Response 
Questionnaire (APQR) (Krystal et al. 1986), and the Observer Alexithymia Scale 
(Haviland et al. 2000). However, these have received little attention in the research 
literature, and therefore will not be discussed further. Likely the most widely used 
interview is the Toronto Structured Interview of Alexithymia (TSIA) created by the 
developers of the TAS-20 questionnaire (Bagby et al. 2006). This measure seems to 
correlate well with the TAS-20 and has shown good psychometric quality (Bagby et 
al. 2006; Grabe et al. 2009). The authors suggested that the validity of alexithymia 
research could be enhanced by employing multiple measurement types 
simultaneously. However, as structured interviews are significantly more time-
consuming compared to self-report questionnaires, their use has been limited, 
especially in studies with larger populations.  
In addition to structured interviews and self-report questionnaires, some 
projective techniques for measuring alexithymia have been developed. These include 
the Rorschach alexithymia indices, and the Scored Archetypal Test, but these have 
also received little attention in alexithymia research (Taylor et al. 1997).  
2.4 Validity of the Alexithymia Construct and its 
Measurement 
The construct of alexithymia has been somewhat controversial from the beginning, 
and some researchers have questioned both its validity, as well as reliable 
measurement (Lane et al. 2015). Apfel & Sifneos (1979) already acknowledged that 
the question of whether alexithymia was best measured by self-report or interview 
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was unresolved. Lane et al. (1997) were the first to argue that the TAS-20, or self-
report questionnaires in general, may be unsuitable for assessing the capacity to 
identify feelings, especially among those who putatively lack such a capacity. 
Despite of this valid and important criticism, available evidence supports the 
convergent and discriminant validity of self-report measures of alexithymia. For 
example, individuals scoring high in alexithymia or its dimensions, use less 
emotional words and show diminished physiological responses to emotion-eliciting 
stimuli (Roedema & Simons 1999; Davydov et al. 2013). TAS-20 scores are also 
negatively associated with empathy (Grynberg et al. 2010), emotional intelligence 
(Parker et al. 2001), and an observer-rated measure of emotional awareness (Levels 
of Emotional Awareness -Scale, LEAS) (Maroti et al. 2018). Importantly, 
alexithymia has been consistently associated with deficits in processing emotional 
facial expressions, regardless of their valence (Grynberg et al. 2012). Together these 
findings support the validity of self-report questionnaires in assessing alexithymia 
and imply that even alexithymic individuals are at least to some extent conscious of 
their own deficits in emotional processing. However, it is plausible that many 
individuals with alexithymic features may not perceive their lack of emotional 
awareness as a problem or deficit, and thus self-report questionnaires such as the 
TAS-20 may not identify them.  
It seems that empirical research on alexithymia faces an insurmountable 
problem: Emotional experience and awareness of it, are among the most intimate 
aspects of the human psyche. Therefore, all attempts to measure them depend at least 
to some extent either on the subjects own, or the interviewer’s personal judgement. 
This problem is of course not unique to alexithymia research, but to different degrees 
concern most areas of psychology and psychiatry, where researchers are interested 
in the characterization of subjective experience.  
Another relevant critique concerns the discriminant validity and stability of the 
alexithymia construct. Several authors have argued that the TAS-20 has overlap with 
negative affectivity and could therefore more accurately depict general distress or 
negative affect in psychiatric patients, instead of measuring true alexithymia. More 
specifically, individual studies have observed that the differences in alexithymia 
levels between patient populations and healthy controls, as well as the relationship 
between alexithymia and somatoform symptoms disappear after controlling for 
current psychiatric symptomatology (Rief et al. 1996; Marchesi et al. 2014; Marchesi 
2015). Furthermore, alexithymic traits in patients suffering from substance abuse 
might be at least partially a state-dependent phenomenon that is relieved following 
withdrawal (de Haan et al. 2012), although findings are mixed (de Timary et al 
2008b).  
As a response to the abovementioned critique, several studies have investigated 
the independent contribution of alexithymia to other traits and states, while 
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controlling for current depressive and anxiety symptoms. This line of research 
largely supports the validity of alexithymia as an independent construct. For 
example, alexithymia correlated with somatization even after controlling for the 
effects of somatic diseases, depression, anxiety and sociodemographic confounders 
(Mattila et al. 2008). Furthermore, the association of alexithymia with deficits in 
emotional processing are at least partially independent from concurrent psychiatric 
symptomatology (Swart et al. 2009; Grynberg et al. 2012). 
Finally, the temporal stability of alexithymia has been examined in several 
follow-up studies (Honkalampi et al. 2000b; Luminet et al. 2001; Saarijärvi et al. 
2006; Tolmunen et al. 2011; Hiirola et al. 2017). Earlier studies focusing on different 
psychiatric patient populations, have reported a lack of stability in alexithymic 
features. Particularly, they have reported that alexithymia levels and especially its 
DIF dimension are, to some degree, affected by changes in mood and anxiety 
(Fukunishi et al. 1997; Marchesi et al. 2008). For example, Honkalampi et al. 
(2000b) observed that alexithymia scores lack absolute stability in depressed 
patients, and that reductions in depressive symptoms associate with concurrent 
reductions in TAS-20 scores. However, subsequent studies have distinguished 
between absolute (absolute change in alexithymia scores over time) and relative 
(relative differences in alexithymia scores between individuals) measures of stability 
of alexithymia. A large 11-year follow-up study by Tolmunen et al. (2011) observed 
slight reductions in alexithymia scores over the follow-up period but nonetheless 
found high absolute and relative stability over time. Saarijärvi et al. (2006) followed 
a sample of patients suffering from major depression for a period of 5 years. In their 
study, alexithymia failed to show absolute stability, but changes in alexithymia 
scores were very small compared to reductions in depressive symptoms. Therefore, 
they concluded that alexithymia is a relatively stable trait that is at least partially 
independent from depressive symptoms. A recent Finnish study also followed a large 
population sample for 11 years, and they reported both high absolute as well as 
relative stability (Hiirola et al. 2017). 
These findings indicate that alexithymia is likely to have both state-dependent as 
well as trait components. This seems to be in line with theories dividing alexithymia 
into primary and secondary forms. Specifically, alexithymia could primarily arise 
from genetic influences and early childhood experiences and manifest as a stable 
trait. However, in other cases, alexithymia could represent a transitory defense 
mechanism following psychic trauma, depression and/or anxiety (Parker et al. 1991).  
A relevant point worth considering in this context, is that personality traits in 
general show only modest stability over the life course (Hampson & Goldberg 2006; 
Edmonds et al. 2013). Furthermore, changes in the ‘Big 5’ -personality traits 
(Norman 1963) such as neuroticism and openness to experience, have been observed 
following use of selective serotonin reuptake inhibitors (SSRIs) (Tang et al. 2009), 
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psychotherapy (Roberts et al. 2017), and psychedelic experience (MacLean et al. 
2011). Therefore, changes in alexithymia levels following improvements in mood or 
abstinence from substance abuse, does not implicate that alexithymia should not be 
considered a personality trait. 
2.5 Prevalence and Sociodemographic Correlates 
of Alexithymia 
Two large population-based studies in Finland and Germany have examined the 
prevalence of alexithymia in the general population, as defined by a TAS-20 score 
of higher than 60 (Bagby & Taylor 1997b). In both studies, the prevalence of high 
alexithymia was 10% (Mattila et al. 2006; Franz et al. 2008). Alexithymia seems to 
represent a dimensional trait that is normally distributed in the population (Salminen 
et al. 1998; Franz et al. 2008), and slightly more prevalent in men (Mattila et al. 
2006; Levant et al. 2009). As comprehensive population-based studies on the 
prevalence of alexithymia have mostly been conducted in modern Western cultures, 
there may be cultural differences in prevalence yet to be discovered. For example, 
some studies suggest that in the Chinese population, alexithymic traits may be 
generally higher (Zhu et al. 2007; Chen et al. 2011). 
Sociodemographic factors associating with alexithymia are low education, 
income and socioeconomic status, being unmarried, as well as poor subjective health 
status (Kauhanen et al. 1993; Joukamaa et al. 1996; Salminen et al. 1996; Mattila et 
al. 2006). Mattila et al. (2006) further observed, in the Finnish general populations, 
that age was strongly associated with alexithymia levels. Specifically, elderly people 
had a higher prevalence of alexithymia. The reason for this finding is not known, nor 
is its generalizability to other countries and ethnicities. In the German population, 
age was not associated with alexithymia (Franz et al. 2008). It seems unlikely that 
alexithymia levels would markedly increase with age, as Hiirola et al. (2017) showed 
robust stability of alexithymia levels in an 11-year follow up, including in older 
individuals. However, different life circumstances and upbringing could explain the 
differences in alexithymia levels between Finnish generations. Fewer people in 
Finland lived in cities in the early 1900s, and rural living has been associated with 
alexithymia (Joukamaa et al. 2007). The elderly generation in Finland has also 
experienced major wars, and thus has likely been more exposed to chronic stress, 
uncertainty and traumatic events. However, this remains speculative, as no specific 
reason has been found for the associations between alexithymia and age.  
Regarding children and adolescents, it is commonly thought that children 
naturally lack the cognitive capacity to accurately identify, differentiate and 
verbalize feelings, and that this ability gradually develops during early adolescence 
(Säkkinen et al. 2007). In existing studies, alexithymia has been measured in 
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adolescents ranging from 12 to 16 years of age, and its prevalence in youth has been 
shown to be comparable to adult prevalence (Horton et al. 1992; Säkkinen et al. 
2007: Joukamaa et al. 2007; Karukivi et al. 2014b). A few studies have examined 
alexithymia levels in children/adolescents ranging from 8 to 14 years of age using a 
questionnaire specifically designed to assess alexithymia in children (Rieffe et al. 
2006; Griffin et al. 2016). However, the exact meaning, stability and clinical 
relevance of alexithymic traits in children and youth is not clear (Säkkinen et al 
2007).  
2.6 Etiology of Alexithymia 
Early theoretical explanations of the etiology of alexithymia ranged from 
psychoanalytic to genetic foundations as well as social learning. Most of these 
studies lacked methodological rigor and thus remained speculative (Lesser 1981). 
However, it was acknowledged from early on that many etiological factors are likely 
to be important in explaining a multifaceted construct such as alexithymia (Lesser 
1981; Taylor 1984). Decades later, several factors increasing the risk for alexithymia 
have been identified, but full understanding of the development of alexithymic 
features is still lacking, as is the state of affairs with most psychiatric problems. 
Studies imply that alexithymia is transmitted intergenerationally, i.e. both parents’ 
alexithymia levels correlate with their children’s (Fukunishi & Paris 2001; Grabe et 
al. 2008). However, this intergenerational transmission can be attributable to both 
genetic and/or environmental (e.g. socioeconomic status, parenting style) factors. 
 Twin studies assessing heritability 
Heiberg & Heiberg (1978) were the first to conduct a twin study of alexithymia in 
33 pairs of twins. They concluded that alexithymia is possibly influenced by genetic 
factors. However, this study was limited by a small sample size and an unvalidated 
measurement of alexithymia. Valera & Berenbaum (2001) analyzed 77 twin pairs 
using the TAS-20 questionnaire. Their results suggested that the EOT dimension of 
alexithymia was most influenced by genetic factors, compared to DIF and DDF that 
were more influenced by shared environmental factors. The sample size also in this 
study limits any firm conclusions. Jørgensen et al. (2007) were first to conduct a 
large study on a sample of 8785 Danish twins with an age range of 20-71 years. They 
also used the TAS-20 to assess alexithymia levels. The results indicated that genetic 
effects were significant across all dimensions of alexithymia (DIF, DDF and EOT), 
as well as high alexithymia (TAS-20 score > 60 points). They estimated a heritability 
rate of 30-33%, with shared environmental factors accounting for 15-20% of the 
variance in alexithymia scores, and nonshared environment for the rest (47-55%). 
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Lastly, Picardi et al. 2011 analyzed a sample of 729 twins from the Italian Twin 
Register, whilst controlling for the effects of concurrent depression. The age range 
of their sample was limited to 23-24 years. This study also used the TAS-20 to assess 
alexithymia. Similarly to Jørgensen et al. (2007), they estimated a heritability rate of 
28-35% for different alexithymia dimensions, with unshared environmental effects 
explaining the majority of variance in alexithymia levels.  
It should be mentioned here that twin studies, although considered the gold 
standard of measuring heritability, have been subject to criticism (Rose 1995; Joseph 
2002; Horwitz et al. 2003; Sapolsky 2017). They rest on the assumption that 
monozygotic and dizygotic twins share equally similar environments and are treated 
similarly by parents, peers and teachers. However, it is likely that compared to 
dizygotic twins, monozygotic twins are treated more similarly, spend more time 
together, share a closer emotional bond, and more often also the same social 
networks (Joseph 2002; Horwitz et al. 2003). These factors together may lead to a 
higher similarity between monozygotic twins that are due to other factors than 
genetic makeup. Therefore, even though twin studies do not support the view of 
alexithymia arising primarily from dysfunctional family environment and quality of 
parenting, this possibility should not be ruled out based on twin studies alone. 
 Candidate genes and gene-environment -interactions 
Few studies exist linking specific genes to alexithymic features. Variants in the 
serotonin transporter-linked promoter region (5-HTTLPR) gene are widely studied 
in psychiatry (Kenna et al. 2012). Kano et al. (2012) were the first to show a positive 
association of the LL-allele of the 5-HTTLPR gene with alexithymia total scores and 
DIF. However, a recent study based on a large population sample reported an 
opposite result, linking the S-allele of 5-HTTLPR with alexithymia. However, the 
effect size was small, especially in comparison to the effect of childhood 
maltreatment (Terock et al. 2018). Individual studies have linked alexithymia to 
genes coding for the brain-derived neurotrophic factor (BDNF), dopamine-receptor 
D2 (Walter et al. 2011), as well as the cathecol-O-methyltransferase (COMT) genes 
(Ham et al. 2005). However, the results have been inconclusive and remain 
unreplicated (Karukivi & Saarijärvi 2014). 
Gene-environment -interactions have become a target of increasing research 
interest as an explanatory model for psychiatric disorders (Caspi & Moffitt 2006; 
Klengel & Binder 2015; Assary et al. 2018). Influential theories such as the 
diasthesis-stress- and differential susceptibility models propose that certain 
individuals are genetically more vulnerable to a given illness such as depression, but 
environmental factors like stressful life-events are needed to trigger this underlying 
vulnerability into an actual disease phenotype (Kendler 2005; Belsky & Pluess 
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2009). Interestingly, evidence of potential gene-environment interactions on the 
development of alexithymia is completely lacking. Terock et al (2018) did examine 
potential interactions between childhood maltreatment and the functional variants of 
the 5-HTTLPR gene, but instead found that both genotype and maltreatment 
independently affected alexithymia levels. 
 Adverse childhood experiences and family 
environment 
Sifneos, in his original paper on alexithymia in psychosomatic patients, did not make 
any speculations about possible etiology. Some years later, Joyce McDougall 
described her frustration and difficulty with alexithymic patients “who seemed 
superficially to have few psychological problems; at the same time they showed a 
rather robot-like adaptation to external reality and little contact with their own 
psychic reality; that is to say they had little identification with others and endlessly 
recounted external events that seemed to have no emotional significance for them” 
(McDougall 1982). Based on clinical observations, she remarked that alexithymic 
patients often depicted caregivers that were emotionally absent due to mental illness, 
or who invalidated, restricted, and/or were disinterested in their child’s emotional 
experience. She argued that parents’ attempts to control the child’s affective 
expression, if repeated and sustained, may cause the child to end up feeling confused 
about emotions, and whether it is allowed to have emotions at all (McDougall 1982).  
In later decades, the association of alexithymia with familial factors has been 
extensively studied. This body of research has provided empirical support for the 
association of alexithymia with parenting styles and parent-child interaction. A meta-
analysis examining the impact of parental bonding in alexithymia, found moderate 
to strong negative correlations between maternal care, and overall alexithymia 
levels, as well as DIF and DDF, but not EOT. Both maternal and paternal 
overprotection also positively associated with alexithymia levels. They described 
this parenting style as ‘affectionless control’, characterized by a lack of adequate 
care, emotional neglect, overprotection and intrusiveness (Thorberg et al. 2011). 
Moreover, retrospective reports of low expressiveness in the childhood family have 
also been associated with higher alexithymia scores (Berenbaum & James 1994; 
Kench & Irwin 2000). Even if based on subjective and retrospective accounts, these 
findings support the early hypotheses on the influence of parenting on alexithymia. 
Other family environmental factors that increase the likelihood of alexithymia 
include low socioeconomic status and low education level (Kokkonen et al. 2001). 
However, it is unclear whether these correlations are direct, or mediated by genetics 
and/or parenting style. 
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Different forms of childhood maltreatment (CM) have been identified as strong 
risk factors for a myriad of psychological and psychiatric problems (Green et al. 
2010; Nemeroff 2016). CM is usually divided into 5 types: Physical abuse and 
neglect, emotional abuse and neglect, and sexual abuse (Mandelli et al. 2015; Infurna 
et al. 2016). Of these, physical and sexual abuse are historically the most extensively 
studied (Infurna et al. 2016), while the different forms of childhood neglect have 
received less attention in the research literature (Stoltenborgh et al. 2013). 
Experience of CM broadly affects both cognitive and affective development and later 
functioning (Pechtel & Pizzagalli 2011). For example, children with a history of 
maltreatment show difficulties in identifying facial expressions, attentional biases to 
negative emotional stimuli, as well as aberrant brain limbic system structure and 
function (Pechtel & Pizzagalli 2011; Teicher & Samson 2013). In light of these 
findings, it is plausible that CM plays some etiological role also in alexithymia. 
Disturbances in parent-child interaction, especially in the form of abuse and neglect, 
could provide inadequate models and lack of positive reinforcement for emotional 
expression, thus leading to deficits in the domains of emotional awareness and 
regulation (Brown et al. 2016). 
Many studies have examined the association between different forms of CM and 
alexithymic features. Kooiman et al. (2004) found no association between physical 
or sexual abuse and alexithymia. However, they did not examine emotional abuse or 
either form of childhood neglect. Joukamaa et al. (2008), in a Finnish study of 
patients attending primary care and psychiatric clinics, found that all forms of CM 
were associated with alexithymia, although only physical abuse in men remained 
significant after adjustments for concurrent psychopathology.  
Emotional maltreatment (either abuse or neglect) may have specific harmful 
effects for the development of affective functioning, such as emotional clarity (Jessar 
et al. 2017). Aust et al. (2013) analyzed a sample of alexithymic individuals and a 
non-alexithymic control group and found that emotional neglect was the only form 
of CM associated with high levels of alexithymia, explaining 13% of the variance in 
alexithymia levels. Emotional abuse, physical abuse or neglect, or sexual abuse had 
no effect on alexithymia levels. In contrast, a recent study found positive associations 
between alexithymia, emotional neglect, emotional abuse, as well as physical 
neglect. However, alexithymia was a mediator between emotional neglect and 
internalizing symptoms, but not between other types of CM, suggesting that 
emotional neglect may be the most important form of CM in the development of 
alexithymia (Brown et al. 2016). These findings are consistent with early 
observations and speculations about the etiology of alexithymia. That is, children 
whose emotional needs are repeatedly and habitually unmet or ignored, may develop 
deficient emotional awareness and emotion regulation skills, manifesting as an 
alexithymic phenotype in some individuals. 
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Taken together, the evidence is inconclusive about which specific type of CM 
may lead to later alexithymia, although emotional types of maltreatment show more 
consistent positive associations. One crucial problem with studies linking specific 
types of CM to mental health outcomes is that different forms of CM are highly 
intercorrelated and co-occurring in the same families (Green et al. 2010; Vachon et 
al. 2015). For example, physical or sexual abuse in the absence of emotional 
maltreatment may be rare. Therefore, attempts to differentiate between effects of 
individual CM types by statistical methods are likely to be limited, and could even 
produce false results (Vachon et al. 2015). Therefore, no strong evidence exists on 
the differential impacts of CM types on alexithymic features.  
It may seem contradictory that childhood experiences are strongly associated 
with alexithymia, while twin studies have shown that shared environment accounts 
for only a small proportion of alexithymia levels. However, as discussed above, the 
methodology and assumptions in twin studies are not scientifically undisputed. 
Furthermore, gene-environment effects could also play a role in explaining this 
discrepancy. Genes are unlikely to act alone in determining complex cognitions, 
affects and behaviors; rather, their expression and effects are in most cases dependent 
on environmental effects and life experiences (Ottman 1996; Kendler 2005; Belsky 
& Pluess 2009). Moreover, genes and nonshared environment could also confer 
resilience, protecting some individuals from the harmful effects of adverse childhood 
experiences (Davydov et al. 2010).   
 Parent-child attachment 
Considering the mechanisms of how CM leads to psychopathology, attachment 
theory, first outlined by Bowlby (1958), is an extensively researched field 
(Mikulincer & Shaver 2012; Widom et al. 2018). Attachment theories hold that 
children are born with an innate tendency to seek proximity to caregivers in times of 
need. If parents fail to adequately respond to their child’s emotional needs, they may 
develop a sense of insecurity in human interaction and form negative representations 
of self and others. This is referred to as insecure attachment, which in infants can 
take the form of anxious, avoidant, or disorganized attachment style. (Mikulincer & 
Shaver 2012, Fearon & Roisman 2017). An insecure attachment formation in 
childhood may interfere with the child’s cognitive and affective development, 
increasing the risk for mental health problems in later life (Belsky 2000; Mikulincer 
& Shaver 2012; Moutsiana et al. 2014). The framework of attachment was later 
extended and applied for adult close relationships (Hazan & Shaver 1987). 
Attachment patterns are relatively stable from infancy to adulthood, and thus adult 
attachment style is thought to largely reflect attachment experiences in infancy and 
childhood (Waters et al. 2000; Fraley 2002).  
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Alexithymia has been consistently associated with both deficits in parental 
bonding, and insecure attachment styles, particularly avoidant attachment. Thus, 
several researchers have argued that alexithymia could arise from childhood neglect 
and/or inadequate parental bonding, leading to an insecure attachment formation and 
harmfully affecting the development of emotional differentiation and regulation. 
(Troisi et al. 2001; Montebarocci et al. 2004; Taylor & Bagby 2004; O’Loughlin et 
al. 2018; Lyvers et al. 2019) More specifically, in an emotionally unsafe environment 
children may learn to suppress unwanted emotions. When the identification, naming 
and expression of emotions are not encouraged, emotion regulation skills may cease 
to develop adequately (Taylor & Bagby 2004; O’Loughlin et al. 2018). However, 
studies linking alexithymia with parental bonding and attachment insecurity have 
been retrospective, and therefore no firm conclusions can be made concerning the 
role of attachment formation in the etiology of alexithymia. 
 Sociocultural factors 
Growing evidence shows that the perception and expression of emotions are likely 
to be shaped (among other factors) by cultural influences (Feldman Barrett et al. 
2011). Lesser (1981) remarked that alexithymia is a product of Western philosophy 
and the psychodynamic framework, which makes the implicit “value judgement that 
verbal expression of emotion is healthy and mature”. He argues that this is not 
necessarily the case in many other cultures and traditions. Dion (1996) examined 
cultural factors in alexithymia prevalence and reported that native Chinese-language 
speakers scored higher in alexithymia scores compared to the native English and 
native European language speakers. He proposed that the Chinese culture encourages 
a more ‘somatic’ form of expressing emotions, compared to verbal expression that 
is the norm in Western countries. Furthermore, he warned against applying the 
alexithymia construct and directly translating Western self-report questionnaires to 
cultures where emotional expression may be conceived of differently. Le et al. 
(2002) compared Asian and Malaysian Americans to European Americans and found 
that Asian and Malaysian Americans had higher levels of alexithymia. Asian 
Americans also reported that their childhood families displayed less physical 
affection and positive expression of feelings. Dere et al. (2012) specifically studied 
the role of cultural values in alexithymic traits, and found that Chinese Canadians, 
compared to Euro-Canadians scored higher in the EOT dimension of alexithymia, 
and that EOT was negatively predicted by modernization and Euro-American values.  
In addition to cultural influences, gender differences have been observed in the 
prevalence of alexithymia: Men typically score higher in alexithymia levels, 
although this has not been the case in all studies (Reviewed in Mattila 2008). Several 
theorists argue that men and women are culturally treated differently by their parents, 
2.6.5
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peers, and other adults, possibly affecting the perception and expression of emotion. 
For example, crying and displays of sadness are discouraged in boys, and politeness 
more encouraged in girls (Garner et al. 1997; Le et al. 2002; Chaplin et al. 2005). Le 
et al. (2002), in the study focusing on cultural differences in alexithymia, also 
observed that men in both cultures have experienced less physical affection 
compared to women, and European American men experienced less difficulties in 
expressing emotions compared to Asian American men. However, gender 
differences alone in alexithymia were not significant in this study. Levant has argued 
that cultural socialization of gender roles could enforce alexithymic traits in males. 
He called this notion ‘normative male alexithymia’ (Levant 1992). More recently, 
Levant et al. (2009) conducted a meta-analysis to examine gender differences in 
alexithymia, and found that men generally score higher in alexithymia, although the 
effect size was small. Research has so far remained scarce on the cultural influences 
and gender socialization as etiological factors in alexithymia.  
 Neural correlates of alexithymia 
A clearer understanding of the underlying neurobiological basis of alexithymia is 
likely to help in illuminating its nature and etiology. However, to avoid simplistic 
biological reductionism, it should be noted that even well-established 
neurobiological correlates are not etiological explanations in themselves (Kendler 
2008; Maj 2013; Borsboom et al. 2019). Neural structure and function are 
determined by a complex interplay of genes, early environment and experiences 
during the life course (Kendler 2005; Belsky & Pluess 2009). Therefore, 
psychological, social, genetic and neurobiological explanations are not mutually 
exclusive, but represent different levels of explanation (Kendler 2012).  
Paul McLean, based on the concept of the triune brain, hypothesized that 
psychosomatic phenomena could be explained by a failure of communication 
between the more evolutionarily ancient rhinencephalon (visceral brain) and the 
neocortex. This disconnection, he postulated, would block intellectual evaluation 
and symbolic representation of emotional information, and it would instead find an 
outlet through the autonomic nervous system. This theory was later applied to the 
alexithymia concept particularly (Lesser 1981). A similar early theory on the 
neurobiology of alexithymia involved deficits in interhemispheric transmission and 
inadequate left-hemisphere dominance. This theory was based on the idea that the 
brain’s right hemisphere is specialized in the perception and processing of emotional 
information, whereas the left hemisphere was thought to specialize in processing 
linguistic information (Silberman & Weingartner 1986; Tabibnia & Zaidel 2005). It 
had been observed that patients who had undergone surgical commissurotomies 
(‘split-brain’ patients) for epilepsy, exhibited similar features compared to 
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alexithymia (Hoppe 1977). Some empirical evidence supports these theories, 
showing that alexithymia may be associated with a left-hemisphere dominance in 
tasks involving the processing of emotional information (Jessimer & Markham 1997; 
Bermond et al. 2005; Tabibnia & Zaidel 2005; Kano & Fukudo 2013), as well as a 
deficit in interhemispheric transmission (Romei et al. 2008). Furthermore, 
alexithymia may occur more frequently following a stroke in the right hemisphere 
compared to the left (Spalletta et al. 2001). 
In later decades, the line of research examining the neurobiology of emotion 
regulation has also informed the contemporary search for the neural basis of 
alexithymia. Circuits comprising numerous brain areas are implicated in the 
perception and regulation of emotion in humans. These include prefrontal cortical 
areas such as the orbitofrontal cortex (OFC), ventromedial prefrontal cortex and the 
anterior cingulate cortex. Other areas include the amygdala, hippocampus, 
hypothalamus, insula and ventral striatum (Davidson et al. 2000; Taylor & Liberzon 
2007). Indeed, a recent meta-analysis of structural brain imaging studies in 
alexithymia found consistently smaller brain volumes in alexithymic individuals in 
the insula, amygdala, OFC and striatum (Xu et al. 2018). 
In functional neuroimaging studies, using emotion tasks involving emotion 
processing, alexithymia has been associated with increased activity of the anterior 
(ACC) and middle cingulate cortex, as well as decreased activities in the amygdala, 
fusiform gyrus, premotor areas, dorsomedial PFC as well as the right insula (van der 
Velde et al. 2013). Most of these associations were specific to emotional valence, 
but the increased activity in the anterior and middle cingulate cortex was independent 
of valence (van der Velde et al. 2013). This finding is in line with the ‘blindfeel’ 
hypothesis of Lane et al. (1997), arguing that alexithymia results from a 
dysfunctional ACC, leading to reduced conscious experience of emotion. Therefore, 
increased activity of the ACC could possibly reflect increased cognitive demand in 
alexithymic individuals when presented with an emotional processing task (van der 
Velde et al. 2013). However, also discrepant findings with decreased ACC activity 
in alexithymic individuals have been reported (Kano et al. 2003; Karlsson et al. 
2008). 
The insula is another region of interest in functional neuroimaging studies of 
alexithymia. The anterior insula (AI) is thought to receive interoceptive signals from 
the body and integrate them into emotional experience (Graig 2009; Gu et al. 2013; 
Namkung et al. 2017). Indeed, decreased empathic responses in the AI have been 
reported to correlate with higher TAS-20 scores (Bird et al. 2010). Furthermore, a 
case-control study of combat veterans with traumatic brain injury showed that 
damage to the AI was associated with alexithymia (Hogeveen et al. 2016). 
Importantly, Ernst et al. (2014) showed that alexithymia was related to both 
decreased interoceptive awareness, and deviant neurotransmitter concentrations in 
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the AI and ACC. Interestingly, there is also evidence that both childhood 
maltreament and traumatic events in adulthood can affect the structure and function 
of both the insula and ACC (Baker et al. 2013; Heeringa et al. 2013; Teicher et al. 
2014).  
In conclusion, on a whole-brain level, differences in hemispheric specialization 
and transmission could play some role in the deficient cognitive processing of 
emotion in alexithymia. More recent studies, however, have focused on specific 
brain regions, most notably the ACC and AI. Consistent evidence seems to imply 
that the AI, with a key role in emotional awareness and interoceptive processing, 
could be a potential neurobiological mechanism mediating the diminished conscious 
experience of emotion in alexithymic individuals. In line with the theories on 
primary and secondary alexithymia, dysfunction of the AI could in theory result from 
traumatic brain injury or psychologically traumatic event (secondary alexithymia), 
or from chronic early-life stress such as maltreatment. 
2.7 Alexithymia and Physical Health 
As discussed in section 2.2, alexithymia research started with a primary focus on 
psychosomatic diseases. From there on, research interest on alexithymia has spanned 
many medical fields including psychiatry, gastroenterology, cardiology, 
immunology, neurology and dermatology (Guilbaud et al. 2003; Willemsen et al. 
2008; Grabe et al. 2010; Porcelli et al. 2013; Samur et al. 2013; Ricciardi et al. 2015; 
Carrozzino & Porcelli 2018). Health status in alexithymia seems to be broadly 
affected in a harmful way, and increased rates of mortality in alexithymic individuals 
have been observed in two large Finnish studies (Kauhanen et al. 1996; Tolmunen 
et al. 2010). Current theories of alexithymia and health assume that emotion 
regulation deficits in alexithymia may lead to alterations in physiological stress 
regulation and immune system functioning, increasing the risk for both impaired 
psychiatric and somatic health (Guilbaud et al. 2003; Lumley et al. 2007; mattilan 
väikkäristä; Alkan Härtwig et al. 2013).  
 Alexithymia and stress physiology  
A potential underlying mechanism that might explain the increased prevalences of 
both somatic and psychiatric morbidity in alexithymic individuals is chronic stress. 
The hypothalamic-pituitary-adrenal (HPA) -axis is considered one of the main 
components of the human stress response system along with the sympathetic adrenal 
medullary (SAM) -axis (Sapolsky et al. 2000; Kozlov & Kozlova 2014). The SAM 
response is quick, occurring within seconds following stressful stimuli, and results 
in the secretion of catecholamines (adrenaline and noradrenaline) leading to 
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increased heart rate, blood pressure, faster breathing, and glucose release into the 
bloodstream (Sapolsky et al. 2000; Kozlov & Kozlova 2014). The HPA axis 
responds more slowly compared to SAM, and initiates a cascade of hormonal 
release, the end product of which is cortisol. Cortisol is a glucocorticoid steroid 
hormone that is a crucial component in stress responses, inducing a number of 
adaptive physiological changes (Sapolsky et al. 2000). Different methods of 
measuring peripheral cortisol levels have been widely used to assess both acute and 
chronic stress (Russell et al. 2012; Kozlov & Kozlova 2014). 
As briefly discussed in section 2.2, Martin & Pihl (1985) were first to propose a 
link between alexithymia and physiological stress, arguing that the decreased ability 
to process emotional information would lead to prolonging of stress responses. For 
example, alexithymic individuals display higher resting heart rate and blood 
pressure, which has been interpreted as a sign of heightened SAM activity (Papciak 
et al. 1985; Wehmer et al. 1995). However, discrepant results have also been reported 
where no differences in resting cardiovascular parameters were observed between 
alexithymic and non-alexithymic older individuals (Waldstein et al. 2002). Later 
findings imply that instead of simply being related to increased hyperarousal and 
stress-responses, alexithymia may lead to a dissociation of subjective and objective 
measures of arousal and stress. This is known as the ‘decoupling hypothesis’ 
(Papciak et al 1985). However, evidence concerning this hypothesis is somewhat 
contradictory, some studies showing differences only in subjective ratings, and 
others in physiological measures of stress (Papciak et al. 1985; Stone & Nielson 
2001; Bermond et al. 2010; Pollatos et al. 2011; McIntosh et al. 2014; Kleiman et al. 
2016). 
Recent studies regarding alexithymia and stress have focused more on cortisol-
related measures, an early study examining the link between alexithymia and 
reactivity in the dexamethasone suppression test, found that alexithymia, but not 
clinical depression was related to a positive result in the dexamethasone suppression 
test, reflecting an abnormal cortisol-related stress response (Lindholm et al. 1990). 
The association was independent of age, as well as socioeconomic and marital status. 
Alkan Härtwig et al. (2013) studied a sample of healthy alexithymic individuals with 
a non-alexithymic control group. They showed a lower cortisol awakening response 
in the alexithymic group, possibly reflecting effects of chronic stress exposure. Two 
studies have examined the association of alexithymia and cortisol responses during 
a social stress test. The first study showed higher salivary cortisol concentrations in 
alexithymic individuals only when anticipating the stressor (De Timary et al. 2008a). 
Similarly, the second study showed higher overall cortisols concentrations before, 
during and after the stress-test in alexithymic individuals (Hua et al. 2014). 
One limitation of existing studies on alexithymia and stress is a predominant 
focus on acute stress markers in experimental settings. In other words, biomarkers 
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reflecting chronic levels of stress have been less explored. Furthermore, the 
associations between individual alexithymia dimensions and stress markers remain 
unclear. As the affective (DIF & DDF) and cognitive (EOT) components of 
alexithymia are differentially associated with psychopathology, they may also show 
differences in terms of physiological stress.  
 Alexithymia and metabolic health 
In addition to psychiatric and psychosomatic disease, later research has implicated 
alexithymia in many somatic health problems that inflict the most disease burden in 
Western developed countries. These include obesity, hypertension, type II diabetes 
and cardiovascular disease (Elfhag & Lundh 2007; Grabe et al. 2010; Tolmunen et 
al. 2010; Lemche et al. 2014). Several mechanisms could possibly link alexithymia 
to impaired physical health. Alexithymia may associate with an unhealthier diet 
(Honkalampi et al. 2017), increasing the risk for lifestyle diseases. Other lifestyle 
factors are also likely involved such as lack of exercise (Helmers & Mente 1999). 
Chronic stress in alexithymia (discussed further in section 2.8.6) could also have a 
synergistic effect with lifestyle factors in promoting weight gain (Sinha & Jastreboff 
2013). However, the direction of causality could also be reverse with physical illness 
affecting emotion processing and alexithymia levels; or alternatively, alexithymia 
and physical disease could be linked via a shared risk factor (Lumley et al. 1996). 
Alexithymic individuals consistently show higher body weight and an increased 
prevalence of obesity compared to controls. However, findings concerning the link 
between alexithymia dimensions and body weight are inconclusive: Fukunishi & 
Kaji (1997) found that obese individuals scored higher in EOT compared to normal 
weight controls, but not in DIF or DDF. A later study reported opposite findings, 
showing that obese individuals compared to controls scored higher in DIF and DDF, 
but not EOT (Pinna et al. 2011). Elfhag & Lundh (2007) reported higher scores in 
all alexithymia dimensions in obese women, but only higher DIF and EOT in obese 
men, compared to a normal-weight community sample. 
Regarding cardiovascular health, alexithymia has been consistently linked to 
hypertension in both men and women (Nordby et al. 1995; Todarello et al. 1995; 
Jula et al. 1999). In a sample of 1168 individuals under 65 years of age, and 
representative of the general population, Grabe et al. (2010) showed an association 
of alexithymia with hypertension and atherosclerotic plaques in carotid arteries, even 
after controlling for sociodemographic factors, known CVD risk factors and 
psychiatric symptoms. A Finnish population study published in the same year, 
reported that alexithymia is associated with higher cardiovascular mortality in 
middle-aged Finnish men (Tolmunen et al. 2010). In their study, each one-point 
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increase in the TAS-26 increased the risk of death due to cardiovascular cause by 
2.3%. Mean follow-up time was 20 years. 
 Alexithymia and somatoform/functional disorders 
Somatoform disorders and somatization (redefined in the DSM-5 as Somatic 
Symptom Disorder) refer to persistent physical symptoms where an underlying 
organic disease mechanism cannot be identified (Fink et al. 2005; Mattila et al. 
2008). Somatization is a common problem in primary care, causing a remarkable 
burden due to increased healthcare utilization (Barsky et al. 2005; Fink et al. 2005) 
The term somatization implies that underlying the physical symptoms is a psychiatric 
disorder or mental distress (Fink et al. 2005). Many theories have attempted to 
explain the phenomenon of somatization (Fink et al. 2005; Mattila 2008). 
Psychodynamic theories conceive of somatization as a defense mechanism where 
subconscious drives and conflicts are only partially allowed to manifest via bodily 
symptoms (Taylor et al. 1997; Mattila 2008). More recent theories view somatization 
as abnormal illness behavior, where mental distress is communicated in the form of 
bodily symptoms (Taylor et al. 1997).  
As alexithymia is thought to involve an inability to translate bodily feelings into 
conscious emotional states, it makes theoretical sense that alexithymia would 
predispose individuals to somatization. For example, Krystal (1990) hypothesized 
that alexithymic individuals fail to understand emotions as signals of information 
processing, and instead focus on the physical sensations alone. Several studies have 
indeed shown that alexithymia associates with somatization and physical symptom 
reporting, although some negative findings have also been reported. Furthermore, 
studies have often been conducted in students or clinical populations, and concurrent 
psychiatric symptoms have not been controlled for (reviewed in Mattila 2008). 
Mattila et al. (2008) conducted a study on a large population-based sample 
(N>5000), whilst controlling for the effects of socioeconomic variables, somatic 
disease and psychiatric symptoms. They showed a positive independent association 
of alexithymia with somatization, particularly driven by the DIF dimension.  
In addition to somatization, alexithymia has been associated with other disorders 
considered to have a functional and/or stress-related component, such as irritable 
bowel syndrome (IBS) (Kano et al. 2018) and fibromyalgia (Montoro et al. 2016). 
Functional disorders share a similar definition with somatization, regarded as those 
somatic conditions “which involve disturbance of function without physical 
abnormality." (Berry 2000). In IBS, alexithymia has been identified as a strong 
predictor of symptom severity and associated with gastrointestinal-specific anxiety 
(Porcelli et al. 2014). It has been hypothesized that the increased symptom severity 
in alexithymic individuals could be due to their tendency to excessively focus on, 
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and amplify physiological sensations accompanying emotional arousal, and 
misinterpret them as signs of disease (Surdea-Blaga et al. 2012). Similarly, 
fibromyalgia patients exhibit higher rates of alexithymia compared to healthy 
controls, although the association of alexithymia and pain severity in fibromyalgia 
may be mediated by symptoms of psychological distress (Montoro et al. 2016; Di 
Tella et al. 2017) 
2.8 Alexithymia and Mental Health 
Alexithymia appears to be a transdiagnostic trait associating with many common 
psychiatric disorders. These include depression (Honkalampi et al. 2000a), anxiety 
disorders including generalized anxiety (Onur et al. 2013), panic disorder (Marchesi 
et al. 2005) and obsessive-compulsive disorder (Grabe et al. 2006), several types of 
substance abuse (Haviland et al. 1988; Michael 1990; Thorberg et al. 2009; Dorard 
et al. 2017), psychotic disorders (van Rijn et al. 2011; Kubota et al. 2012), post-
traumatic stress disorder (Yehuda et al. 1997), as well as eating disorders 
(Nowakowski et al. 2013). Because of this transdiagnostic nature of alexithymia in 
psychiatry, it is tentative to conceive of it as a general vulnerability factor increasing 
the risk for psychiatric morbidity. However, as almost all studies have been cross-
sectional, this conclusion is premature. It can also be argued that alexithymia may 
represent a state caused by the disorders themselves, or general distress associated 
with them, as has been discussed in section 2.4.  
Some longitudinal studies have attempted to examine alexithymia as a 
vulnerability factor for mental health disorders, but results have been inconclusive 
(Kojima 2012; Karukivi et al. 2014a). A review of prospective studies of alexithymia 
by Kojima (2012) concluded that evidence of alexithymia as a prognostic risk factor 
for disease is not established. However, studies were few and sample sizes mostly 
small. Karukivi et al. (2014a) did find that the DIF dimension of alexithymia 
increased the risk for future anxiety symptoms in adolescents. Adolescence may be 
a fruitful age to study this issue, as alexithymia can already be measured, but 
psychiatric disorders have often not yet emerged.  
 Alexithymia, depression and anxiety 
The association of alexithymia and depression has been studied in the Finnish 
general population. While the prevalence of alexithymia was only 4.3% among non-
depressed individuals, it was 32.1% in those scoring above 9 points in the Beck 
Depression Inventory (Honkalampi et al. 2000a). Furthermore, depressive symptoms 
explained 29.2% of the variability in alexithymia scores. Because of this large 
overlap, the authors emphasized the need to treat depression as a confounding factor 
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in alexithymia research. Still, many studies imply that despite the strong association 
between depression and alexithymia, they represent at least partly distinct constructs 
(Lipsanen et al. 2004), with alexithymia levels showing more temporal stability 
compared to depressive symptoms (Saarijärvi et al. 2006). 
In addition to depression, elevated rates of alexithymia have been observed in 
many anxiety disorders. In panic disorder, the prevalence of alexithymia seems 
especially high, ranging from 34% to 67% in different studies. Furthermore, high 
alexithymic traits in those suffering from panic disorder, predict worse symptom 
severity (De Berardis et al. 2008). Regarding obsessive-compulsive disorder (OCD), 
Grabe et al. (2006) showed that OCD patients had higher alexithymia levels 
compared to healthy controls, but the first-degree relatives of these groups did not 
differ in alexithymia levels. They thereby concluded that alexithymia is elevated in 
OCD but does not pose a familial risk factor for OCD. A recent review concluded 
that OCD patients show higher alexithymia scores compared to controls, but 
alexithymia levels are not higher in OCD compared to other clinical populations 
(Robinson & Freeston 2014). In anxious adolescents, alexithymia seems to be a 
common trait: Paniccia et al. (2018) studied adolescents with generalized anxiety 
disorder (GAD) and healthy controls, as well as their parents. They showed that 
adolescents suffering from GAD, as well as their mothers, had higher alexithymia 
levels compared to the control group and their mothers. Similarly, a Finnish study in 
a large population-based sample of adolescents showed that alexithymia was 
associated with anxiety, and that the majority of alexithymic adolescents were highly 
anxious (Karukivi et al. 2010).  
Most studies have examined alexithymia as a unidimensional construct, studying 
associations of overall alexithymia scores with mental or physical health outcomes. 
However, it is likely that the individual alexithymia dimensions have differential 
associations with symptomatology and disorders (Bankier et al. 2001). The affective 
dimension (DIF and DDF) of alexithymia is consistently linked to increased 
depression and anxiety, whereas the EOT dimension seems unrelated to them (Grabe 
et al. 2004; Alkan Härtwig et al. 2014). This idea of alexithymia subtypes is further 
explored in section 2.9.1. 
 Alexithymia and psychosis 
An impaired capacity to regulate emotion may be a core component of psychotic 
disorders such as schizophrenia (O’Driscoll et al. 2014; Chapman et al. 2019). Thus, 
alexithymia is also assumed to represent a vulnerability factor for psychosis (Fogley 
et al. 2014; O’Driscoll et al. 2014). A recent study compared patients with 
schizophrenia, their siblings, as well as individuals at ultra-high risk for psychosis 
with healthy controls (van der Velde et al. 2015b). They concluded that all three 
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groups scored higher in cognitive alexithymia compared to controls. Cognitive 
alexithymia was defined here as a subtype with difficulties in identifying and 
describing emotions, but normal levels of fantasizing and emotional arousal. 
Alexithymia has also been associated with poorer neurocognition in schizophrenia 
(Fogley et al. 2014), the authors suggest that self-reflective functions such as the 
awareness and regulation of emotion, may require a certain degree of neurocognitive 
competence. 
 Alexithymia and Autism Spectrum Disorders 
The Autism Spectrum Disorders (ASD) are considered neurodevelopmental 
disorders characterized by pervasive deficits in interpersonal communication, as well 
as repetitive, stereotypic and restricted behaviors (APA 2013). Alexithymia is 
thought to be more prevalent in populations with ASD compared to healthy controls, 
but representative studies with adequate sample sizes are lacking (Kinnaird et al. 
2019). In existing studies, approximately 50% of individuals with ASD seem to have 
co-occurring alexithymia.  
The core characteristics of alexithymia and ASD show some conceptual overlap 
(Fitzgerald & Bellgrove 2006; Poquérusse et al. 2018), which has generated 
interesting research in recent years regarding their differences and similarities. 
Specifically, some researchers consider deficits in emotional processing such as 
lower empathy to represents core characteristics of ASD. Alexithymia and ASD also 
show similar patterns of deficits in emotion recognition and social communication 
(Poquérusse et al. 2018). Recent evidence shows that many of the deficits in emotion 
processing previously considered core components of ASD, may actually be more 
adequately explained by co-occurring alexithymia (Bird & Cook 2013; Kinnaird et 
al. 2019). For example, one study showed that empathic brain responses to other 
peoples’ pain is moderated not by autism, but by alexithymia (Bird et al. 2010). 
Similarly, deficits in emotion recognition from faces may be better predicted by 
alexithymia levels than diagnosis of ASD (Cook et al. 2013). This is not simply a 
conceptual distinction as most, but not all individuals with ASD show moderate to 
high levels of alexithymia (Hill et al. 2004; Bird & Cook 2013). Further studies are 
needed to clarify the prevalence and meaning of alexithymia in ASD, as well as 
whether individuals with co-occurring ASD and alexithymia could benefit from 
individualized treatment.  
 Alexithymia and eating disorders 
Eating disorders comprise a group of disorders related to problematic eating 
behaviors. These include Anorexia Nervosa, Bulimia Nervosa and Binge Eating 
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Disorder. Alexithymic traits have been widely studied in the context of eating 
disorders (Nowakowski et al. 2013; Westwood et al. 2017). A recent systematic 
review and meta-analysis concluded that across the spectrum of eating disorders, all 
diagnostic groups scored higher in alexithymia levels than healthy controls, with 
medium to large effect sizes (Westwood et al. 2017). However, many studies had 
not controlled for concurrent depression and/or anxiety. 
Theories on the etiology of eating disorders share some similarities with the 
assumed origins of alexithymia. It has been suggested that eating disorders develop 
in a childhood family environment which discourages and invalidates emotional 
expression, and that disordered eating behaviors are maladaptive strategies to 
regulate negative affect (Corstorphine 2006; Nowakowski et al. 2013). As supportive 
evidence, some studies have shown that the link between childhood maltreatment 
and eating disorders is at least partially mediated by alexithymia (reviewed in 
Nowakowski et al. 2013).  
 Alexithymia, substance use and addictive disorders 
Problems in emotion regulation have been widely implicated in the etiology of 
substance abuse (Aldao et al. 2010; Morie et al. 2016). Therefore, it is not surprising 
that alexithymia is linked to problematic use of many addictive substances (Haviland 
et al. 1988; Michael 1990; Dorard et al. 2017). An especially high prevalence (30-
49%) of alexithymia has been repeatedly observed in patient populations suffering 
from alcohol dependence (for a review, see Cruise & Becerra 2018).  
The association of alexithymia with substance use in healthier, non-clinical 
populations is less studied (Cruise & Becerra 2018). A Finnish large population-
based study of middle-aged men found that alexithymia was associated with heavier 
alcohol use per occasion, more frequent use as well as binge drinking (Kauhanen et 
al. 1992). They also used biomarkers of alcohol use to validate the self-report data. 
A more recent study also associated alexithymia with heavier drinking patterns in a 
sample of college students (Lyvers et al. 2014). 
The role of alexithymia in tobacco use is also an understudied area. One study 
found that during acute abstinence from tobacco, alexithymia predicted increased 
craving in regular smokers (Sutherland et al. 2013). However, an earlier study found 
no relationship between alexithymia, tobacco use or nicotine dependence in regularly 
smoking adults (Lumley et al. 1994). No studies have so far compared alexithymia 
levels between regular smokers and non-smokers in population-based samples. 
Regarding the use and abuse of other substances and illicit drugs, existing 
research is very scarce. A recent study found a higher prevalence of alexithymia in 
adolescents with cannabis abuse or dependence, compared to healthy controls 
(Dorard et al. 2017). A few studies have observed high alexithymia levels in patients 
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seeking treatment for problematic use of psychoactive substances, but these studies 
have not differentiated between specific substances (Haviland et al. 1988; Michael 
1990). 
In addition to addictive substances, alexithymia could also be associated with 
behavioral addictions. However, this field of research is relatively new, and existing 
studies are few in number. Gambling disorder, currently the only behavioral 
addiction acknowledged by the DSM-5, has been associated with alexithymia 
(Parker et al. 2005; Gori et al. 2016). Other problematic behaviors often 
conceptualized as behavioral addictions such as internet gaming disorder and 
problematic mobile phone use have also been positively associated with alexithymia 
levels in young adults (Mei et al. 2018; Bonnaire & Baptista 2019). 
Different mechanisms have been proposed to explain the link between 
alexithymia and addiction. Lyvers et al. (2019) have studied the role of parental 
bonding and attachment in alexithymic individuals with alcohol abuse. They have 
hypothesized that substance abuse in alexithymia may be a result of an inadequate 
parental bonding, harmfully affecting the development of emotional awareness and 
regulation, thereby promoting substance use as a means to cope with stressful life-
events and difficult emotions. 
Another possible pathway to increased substance use in alexithymia could be the 
increased levels of physiological stress described in detail in section 2.8.1. Chronic 
stress is an important factor in both the onset and relapse in addictive disorders 
(Sinha 2008). For many, substance use can be a coping strategy to alleviate stress, 
particularly social stress (Morris et al. 2005). A study by Kauhanen, however, did 
not find evidence of stress contributing to the increased alcohol use in alexithymic 
men (Kauhanen et al. 1992). They measured job stress and autonomic reactivity to 
physical stress but lacked measures of cortisol reactivity and social stress that may 
be important in alexithymia (de Timary et al. 2008a).  
Preliminary results by Morie et al. (2016) have linked alexithymia to aberrant brain 
responses in the processing of rewards, which could mediate the association with 
substance abuse. Furthermore, individuals with high alexithymia often suffer from 
social anhedonia (Prince & Berenbaum 1993), also reflecting altered reward 
processing in the social domain. Anhedonia is an important phenomenon in addiction, 
possibly increasing the risk for substance abuse, but also resulting from neurochemical 
changes associated with addiction itself (Volkow et al. 2011; Garfield et al. 2014). 
While each of these possible mechanisms behind alexithymia and addiction 
represent a different viewpoint, they are not mutually exclusive. For example, 
difficulties in emotion regulation, interpersonal problems and social anhedonia could 
result from inadequate parental bonding and attachment insecurity, and further lead 
to chronic physiological stress and aberrant reward processing (Spitzer et al. 2005; 
Quirin et al. 2008) 
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2.9 Heterogeneity of Alexithymia 
 Alexithymia subtypes and differences between 
alexithymia dimensions 
It has been pointed out that individuals scoring high on alexithymia scores are not a 
homogenous population, and therefore many researchers have proposed the 
existence of alexithymia subtypes (Bermond et al. 2007; Alkan Härtwig et al. 2014; 
Ueno et al. 2014). Bermond et al. (2007) were the first to hypothesize the existence 
of alexithymia subtypes, based on the division of alexithymia into cognitive 
(identifying, describing and analyzing emotions) and affective (emotionalizing, 
fantasizing) components in the BVAQ questionnaire. According to their model, type 
I alexithymia is characterized by reductions in both cognitive and affective domains, 
while type II alexithymia is a deficit in only the cognitive domain. However, they 
pointed out that theoretically there are 4 extremes (one of which is non-alexithymic) 
depending on which domain is affected (Bermond et al. 2007). They showed 
evidence of these subtypes in several samples using confirmatory factor analysis 
(Bermond et al. 2007). Several studies have later used the distinction of cognitive 
and affective alexithymia in studying differences in emotion regulation and 
associated brain activity (van der Velde et al. 2015a; Goerlich-Dobre et al. 2015). 
However, only one cluster analytical study has been conducted using the BVAQ, and 
this study failed to show evidence of a cognitive and affective subtype (Bagby et al. 
2009). 
Previous evidence indicates that the individual dimensions of the TAS-20 differ 
in their effects on emotion regulation and mental health, supporting the idea of 
possible alexithymia subtypes also based on the TAS-20 (Grabe et al. 2004; Davydov 
et al. 2013; Wiebe et al. 2017). For example, DIF and DDF seem to be more 
consistently associated with psychopathology, compared to EOT (Grabe et al. 2004; 
Conrad et al. 2009). Interestingly, although EOT does not seem to increase the risk 
for psychiatric symptoms, it may be associated with other negative traits such as 
social detachment and impaired cognitive processing (Vanheule et al. 2011), a 
general deficit in empathy (Grynberg et al. 2010), and even psychopathic traits 
(Lander et al. 2012). Furthermore, EOT seems to be associated with reduced 
physiological responses, as well as attention allocation to negative (sad or dysphoric) 
stimuli (Davydov et al. 2013; Wiebe et al. 2017). Together, these results suggest that 
EOT may indeed have different origins and consequences as an emotion processing 
trait, as Preece et al. (2017) hypothesized based on the broader theory of emotion 
regulation. Whereas individuals high in DIF and DDF could be more prone to 
chronic negative affect, and therefore at an increased risk for disorders such as 
anxiety and depression; those high in EOT could instead downregulate negative 
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emotions, leading to detached social behavior and deficits in empathy. It has 
therefore been hypothesized that EOT could be conceptualized as a coping 
mechanism and a possible resilience factor, protecting the mind from extremely 
traumatic events and circumstances (Davydov 2017). 
Some studies have examined possible alexithymia subtypes based on the TAS-
20. However, as the TAS-20 does not acknowledge the purported affective 
dimension of alexithymia, these subtypes are conceptualized differently. Cluster 
analytical studies seem to support the conceptual distinction between DIF/DDF and 
EOT. For example, Chen et al. (2011) examined differences in emotional expression 
and emotion regulation in alexithymics, using cluster analysis. They found three 
subtypes, which they called introvert-high (high in DIF and DDF), extrovert-high 
(high in EOT), and general-high alexithymia (high in all dimensions). Introvert-high 
and general-high alexithymia was associated with suppressive emotion regulation 
and increased psychiatric symptomatology, compared to the extrovert-high group 
and individuals low in alexithymia. Similarly, Ueno et al. (2014) conducted a cluster 
analysis based on the TAS-20 and the Big-5 personality features. They found two 
alexithymia clusters, one scoring high in DIF and neuroticism, and the other high in 
EOT and low in openness to experience. They hypothesized that individuals with 
high DIF/DDF, may not be truly alexithymic, as they are aware of their disposition 
to chronic negative affect, and actively avoid situations where negative affect might 
arise. In contrast, EOT and low openness could represent a ‘truer’ form of 
alexithymia, as EOT is not clearly associated with depression or anxiety, and low 
openness to experience relates to blunted and constricted affect. Finally, Alkan 
Härtwig et al. (2014) used a latent-profile analysis, an found similar subgroups 
compared to previous studies. Their findings implied that individuals scoring high 
specifically in DIF experienced most psychological distress, compared to those 
scoring high on every dimension of alexithymia. These findings seem consistent with 
Davydov’s (2017) argument that EOT could serve as a protective factor in 
alexithymia. Those high in EOT, could be less distressed by reduced emotional 
awareness, as they may be less interested in emotional content to begin with; whereas 
individuals high only in DIF are more aware of their inability to process emotions, 
and suffer more from this trait (Alkan Härtwig et al. 2014). 
 Primary and secondary alexithymia 
The distinction between primary and secondary alexithymia was made soon after the 
conception of the alexithymia construct (Freyberger 1977; Lesser 1981). Primary 
alexithymia is hypothesized to represent a stable, developmental trait that acts as a 
risk factor for disease. In contrast, secondary alexithymia could result for example 
from organic disease or brain injury that compromises emotion regulation abilities; 
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Or alternatively, a major traumatic event, causing the individual to dissociate from 
the painful experience (Lesser 1981). In other words, primary alexithymia is 
regarded as a developmental risk factor for illness, whereas secondary alexithymia 
is thought to be caused by an illness or some other traumatic event. 
Some empirical support for the distinction of primary and secondary alexithymia 
has been obtained. Zeitlin et al. (1989) showed that a sample of Vietnam combat 
veterans had markedly higher alexithymia levels compared to controls. However, in 
a sample of holocaust survivors, PTSD was associated with alexithymia, but 
traumatic events were not. This implies that alexithymia in holocaust survivors could 
be a predisposing factor, or a consequence of chronic PTSD, but does not support 
secondary alexithymia simply due to psychological trauma (Yehuda et al. 1997). A 
later study on victims of sexual assault found that rape victims were more 
alexithymic that controls without sexual trauma history. The effect was independent 
of PTSD, and alexithymia was even higher in individuals with repeated trauma, 
compared to those with a single traumatic event (Zeitlin et al. 1993). 
A study by Spalletta et al. (2001) provided interesting evidence for the existence 
of secondary alexithymia due to stroke. They observed a remarkably high prevalence 
of alexithymia in patients that had suffered a right-hemisphere stroke (48%), 
compared to control patients with a left-hemisphere stroke (22%). Similarly, a 
Finnish study found that patients suffering from traumatic brain injury had higher 
scores on alexithymia measures, compared to a control group matched for age, 
gender and depressive symptoms. However, severity of the injury, MRI findings or 
laterality of injury was not associated with alexithymia in this sample (Koponen et 
al. 2005). Regarding organic disease, several studies have observed high rates of 
alexithymia in cancer patients, although results are inconclusive and lack 
methodological rigor (De Vries et al. 2012). The direction of causality is also unclear 
and could plausibly be bidirectional.  A study by Messina et al. (2011) analyzed a 
sample of oncological patients and showed that although psychological factors 
explained the majority of variance in alexithymia, anemia and the degree of cancer 
invasion were independent predictors of alexithymia levels. This suggests that the 
severity of cancer per se could disturb affective functioning and lead to alexithymia.  
Taken together, these studies support the existence of secondary alexithymia due 
to organic disease, brain injury or traumatic events. However, more studies applying 
a longitudinal setting are needed to adequately address this question. 
2.10 Conclusions based on the Literature Review 
High levels of alexithymia are broadly related to impaired physical and mental 
health. However, the nature of this association remains unclear, as alexithymia has 
not been established as a prospective risk factor for any somatic or psychiatric 
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disease. The nature of alexithymia as a distinct phenomenon from depression or 
anxiety is still also under debate. Regardless, alexithymia associates with aberrant 
processing of emotional information, interpersonal difficulties, as well as increased 
measures of physiological stress (Spitzer et al. 2005; Grynberg et al. 2012; Alkan 
Härtwig et al. 2013). Therefore, it is plausible that alexithymia itself could increase 
the risk for stress-related health conditions. The etiology of alexithymia remains 
unclear. Twin studies suggest a relatively low heritability rate, leaving room for a 
substantial environmental influence. Early-life adversity such as low parental 
socioeconomic status or different forms of childhood maltreatment have been 
associated with alexithymia (Kokkonen et al. 2001; Joukamaa et al. 2008; Aust et al. 
2013). However, the specificity of these associations is unclear as virtually no studies 
have controlled for the effects of other types of early-life adversity such as divorce, 
financial difficulties or mental illness in the childhood family. Most studies have 
examined alexithymia as a unidimensional construct. However, more recent results 
imply that subtypes of alexithymia may lead to very different phenotypes between 
alexithymic individuals (Chen et al. 2011; Alkan Härtwig et al. 2014). While the 
affective dimension (DIF & DDF) of alexithymia has been consistently associated 
with increased psychiatric symptomatology, the cognitive dimension (EOT) has not 
(Grabe et al. 2004). Therefore, studies analyzing alexithymia as a multidimensional 
construct and from a subtype perspective are needed, using diverse health outcomes. 
 
 42
3 Aims 
The aims of this thesis were to further characterize the structure, nature and etiology 
of the alexithymia construct, and to illuminate the significance of individual 
alexithymia dimensions for mental and physical health as well as physiological stress 
measures. Specific aims were: 
1.  To investigate the existence of alexithymia subtypes in the FinnBrain study 
sample, and to compare these subtypes in terms of psychiatric 
symptomatology, diagnoses of depression and anxiety disorders, and 
childhood maltreatment history. 
2.  To examine how different alexithymia dimensions associate with substance 
use (alcohol and tobacco) patterns in men. 
3.  To investigate associations between alexithymia dimensions, overweight and 
gestational diabetes in pregnant women. 
4.  To examine how alexithymia dimensions relate to chronic stress (as measured 
by hair cortisol concentrations) in pregnant women. 
5.  To clarify the etiology of alexithymia by examining its associations with self-
reported early-life adversity.   
6.  To illuminate the relationship between depression and alexithymia, by 
comparing their associations with early-life adversity and adult attachment 
style. 
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4 Materials and Methods 
4.1 Study Design – FinnBrain Birth Cohort Study 
The present study is based on the FinnBrain Birth Cohort study 
(www.finnbrain.fi), a prospective cohort established to study the effects of 
prenatal and early life stress exposure on child brain development and health 
outcomes (Karlsson et al. 2017). Participants were recruited between December 
2011 and April 2015 from maternal welfare clinics in the South-Western Hospital 
District and the Åland Islands in Finland. The study population (N for the whole 
cohort=3808 families) consists of consecutive women attending the free-of-
charge ultrasound in a public healthcare facility [coverage close to 100% in the 
population (www. thl.fi)] at gestational week 12, their children-to-be-born, as well 
as fathers of the children/partners of the mothers. After recruitment, the 
participants filled in a set of self-report questionnaires three times during 
pregnancy, at gestational weeks 14, 24, and 34. After birth, the families are 
followed up at three- to six-month intervals (the first 30 months) or 12-to 36-
month intervals (from 36 months onwards) and the study is planned to continue 
for decades. The focus of the FinnBrain project is primarily neurodevelopmental 
and aims to identify biomarkers for prenatal- and early-life stress exposures, as 
well as trajectories for psychiatric and somatic morbidity.  
4.2 Subjects in studies I-V 
In the present study, the focus was exclusively in adults (parents participating in 
the FinnBrain Birth Cohort). In studies I-III and V, we included all subjects who 
had filled in the relevant questionnaires. In study IV, we included those mothers 
who had their hair samples collected and cortisol levels successfully analyzed. 
Study I included 994 fathers and 1992 mothers. Study II focused on men only and 
included 994 fathers. Study III focused on women only and included 1660 
mothers. Study IV included 130 mothers. Study V included 1713 mothers and 882 
fathers.  
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4.3 Sociodemographic variables 
 Age 
Subjects reported their age when entering the FinnBrain Study at the first maternal 
ultrasound at gestational week 12. Age was applied as a control variable in all studies 
and was used as a continuous variable. 
 Parity 
Information on parity was asked in the first trimester and was coded dichotomously 
as 1. Primiparous and 2. Multiparous. Parity was used as a control variable in study 
III.  
 Education 
Education was either divided into three classes: 1. High school or lower; 2. 
Vocational / upper secondary school degree; 3. Applied sciences / University degree 
(Studies I and V); Or into five classes (studies II-IV): 1. High school or lower; 2. 
Vocational degree; 3. Upper secondary school; 4. Applied sciences or bachelor’s 
degree; 5. Graduate school or PhD degree. 
 Income 
Individual income of both mothers and their partners was asked on recruitment into 
the study and was divided into four categories: 1. < 1000€/month, 2. 1000–
2000€/month, 3. 2000–3000€/month and 4. > 3000€/month. 
4.4 Questionnaires 
 Alexithymia 
For measuring alexithymia, we applied the Toronto Alexithymia Scale (TAS-20) 
(Bagby et al. 1994; Joukamaa et al. 2001; Taylor et al. 2003): The TAS- 20 is one of 
the most commonly used self-report scales used to measure alexithymic features, it 
has been validated in several languages including Finnish (Joukamaa et al. 2001; 
Taylor et al. 2003). It consists of 20 items divided into three subscales: difficulty 
identifying feelings (DIF), difficulty describing feelings (DDF) and externally 
oriented thinking (EOT). Items are rated with a 5- point Likert-scale (1=Strongly 
disagree, 5=Strongly agree). Thus, the total score ranges from 20 to 100. An 
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individual is considered “high” in the alexithymia scale if the TAS-20 total score 
exceeds 60 points, and “moderate” if the total score is between 52 and 60 points 
(Taylor et al. 1997). The TAS-20 was sent to the study participants when their baby 
was 6 months old. 
 Depressive symptoms 
The Edinburgh Postnatal Depression Scale (EPDS) (Cox et al. 1987) is a widely used 
questionnaire for screening pre- and postnatal depression, but the questionnaire has 
also been validated in men (Edmondson et al. 2010). It is a 10-item self-report scale 
asking respondents to rate their mood and other symptoms related to depression 
during the previous week. Questions are scored from 0 to 3 and thus, the total score 
ranges from 0 to 30 points. Cut-off points for “possible” and “probable” depression 
have been suggested at 9/10 and 12/13 points, respectively (Gibson et al. 2009). The 
EPDS has also shown good psychometric properties in Finnish mothers (Tamminen 
1990). The EPDS was sent to the study participants in the 1st, 2nd and 3rd trimesters, 
and when the baby was 3 and 6 months old.  
 Anxiety symptoms 
The Symptom Checklist-90 (SCL-90) (Derogatis et al. 1973; Holi et al. 1998) is a 
self-report questionnaire to assess intensity of symptoms on many domains of 
psychopathology. In the present studies, only the anxiety subscale was used. This 
subscale asks the respondent to report anxiety symptoms experienced during the 
previous month. The items are rated on a 5-point scale ranging from 0 (not at all) to 
4 (extremely). The total score of the anxiety subscale ranges from 0 to 40 points. The 
SCL-90 anxiety scale was sent to the study participants in the 1st, 2nd and 3rd 
trimesters, and when the baby was 3 and 6 months old.  
 Adult Attachment 
Adult Attachment Style was assessed in study V using the Experiences in Close 
Relationships -questionnaire (ECR-R, Fraley et al. 2000). The ECR-R is a 36-item 
questionnaire divided into two dimensions of attachment anxiety and avoidance. It 
measures adult attachment security in romantic relationships. Items are scored on a 
seven-point scale from 1 (strongly disagree) to 7 (strongly agree). Higher scores 
indicate attachment insecurity. The dimension of attachment anxiety reflects 
preoccupation and worry concerning the relationship and the partner’s emotional 
availability. Attachment avoidance reflects distrust and avoidance of emotional 
closeness, as well as repeated attempts to maintain independence, emotional distance 
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and self-reliance (Miculincer & Shaver 2012). The ECR-R was administered to study 
participants in mid-pregnancy 
 Prescription drug use 
Prescription drug use during pregnancy was asked in the second and third trimesters 
and was used as a control variable in study III. We included use of antidepressant 
(SSRI or SNRI) and glucocorticoid medications. 
 Substance Use 
Questionnaires sent in the first trimester (T1) and 3 months after the baby was born 
(T2) asked about current alcohol, tobacco, and illicit drug use. Regarding alcohol, 
frequency of use was divided into six categories: 1. Never; 2. Less than monthly; 3. 
Once or twice per month; 4. Weekly; 5. Several times a week, and 6. Daily. Quantity 
of alcohol use per occasion was asked in standard doses of 12 g of ethanol. It was 
further clarified that a standard dose of alcohol is equivalent to a bottle (0,33 litres) 
of beer or a glass (12 cl) of wine. Similarly, quantity and frequency of tobacco use 
was asked. Alcohol and tobacco use were the main outcome variables in study II. In 
study III and IV, alcohol and tobacco use in women during pregnancy was initially 
used as a control variable but dropped out of final analyses as reported consumption 
in women was negligible. 
 Body Mass Index 
Body Mass Index was used as an outcome variable in study III. The information was 
obtained from the Finnish Medical Birth Register kept by the National Institute of 
Health and Welfare (THL; www.thl.fi). Data on weight was based on self-reported 
weight before pregnancy, and BMI was calculated in the maternal welfare clinic at 
gestational week 12.  
 Gestational Diabetes  
Screening for gestational diabetes was conducted in gestational weeks 14-16 or 24-
26, depending on the mother’s potential risk factors (Current Care Guidelines 2013).  
Diagnosis of gestational diabetes was confirmed if fasting glucose was > 5.3 mmol/l, 
if the 1-hour value of the glucose tolerance test was > 10.0 mmol/l, or if the 2-hour 
value was > 8.6 mmol/l (Current Care Guidelines 2013). This data was also drawn 
from the Finnish Medical Birth Register. We only had access to diagnoses of 
gestational diabetes, not the actual measurement values. 
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 Hair Cortisol Assessment (Study IV) 
Hair samples were collected from a random population of mothers participating in 
the FinnBrain Cohort at the hospital maternity ward 1 – 3 days after delivery. A 
strand of hair was cut from a standardized area of the posterior vertex region of the 
head as close to the scalp as possible. Hair samples were stored in foil in a dry place 
protected from light according to good research practice, Finnish legislation and data 
protection until the analyses. The analyses were performed at Life and Health 
Sciences Research Institute (ICVS), University of Minho, Portugal. For the analysis, 
a 5 cm segment was cut from the samples and 5 - 15 mg of each sample was analysed. 
As hair grows approximately 1 cm per month, a 5 cm segment was estimated to 
reflect the cortisol concentrations of the previous five months. 
The hair segments were washed in isopropanol three times for three minutes and 
finely minced using surgical scissors. For extraction of cortisol, 1.5 ml of methanol 
was added to each sample and the samples were incubated at 55°C for 24h. After 
centrifuging at 10000 rpm for 2 minutes, the supernatant was transferred to a new 
vial. Methanol was evaporated at 60°C under a constant stream of nitrogen until the 
samples were dried completely. Finally, 0,15 mL of phosphate buffer was added and 
50 μL of each sample was analysed with ELISA (IBL International Cortisol Saliva 
ELISA) following the manufacturer’s procedure. All samples were analyzed in 
duplicates with coefficients of variation below 13%. Values above 3 standard 
deviations (SD) above the mean were considered as outliers and excluded from the 
final analyses (HCC > 190.5 pg/mg, N=5) (Stalder et al. 2017). Hair samples 
weighting under 5 mg (N=0) or more than 15 mg (N=7) were also excluded. 
 Early-life Adversity 
The Trauma and Distress Scale (TADS) (Salokangas et al. 2016) was used to assess 
childhood maltreatment (CM). The TADS is a 43-item self-report questionnaire 
developed to assess childhood maltreatment retrospectively. It includes five 
categories of maltreatment: emotional and physical abuse, sexual abuse, emotional 
neglect, and physical neglect. Frequency of maltreatment exposure is assessed using 
a five-point scale (0 = never, 4= almost always). Other types of EA were assessed 
using the Health 2000 -questionnaire (Heistaro 2008). Parental common psychiatric 
disorders (Major Depression, anxiety disorders, eating disorders, psychotic 
disorders, bipolar disorder or ADHD), substance abuse, as well as parental divorce 
during childhood, were asked as single yes/no questions. Financial problems in the 
childhood family were also assessed by a single item: “There were long-term 
financial difficulties in my childhood family”, using a five-point scale (0 = never, 4= 
almost always). This measure was dichotomized in the same way as the TADS 
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maltreatment domains. The TADS and Health 2000 questionnaires were 
administered in the first trimester of pregnancy.  
4.5 Statistical analysis 
All statistical analyses in all the studies were conducted using the IBM SPSS 
software (version 22 or 24). In all studies, the limit for statistical significance was 
deemed at p<0.005 (two-tailed). 
 Study I 
Normality of distribution within the continuous variables was tested using the 
Shapiro-Wilk test. As TAS-20, SCL-90 and EPDS scores were all non-normally 
distributed, Mann-Whitney U test was used to analyze group differences for these 
variables and Spearman’s rho (ρ) was used in the correlation analyses. Chi square 
test was used to assess group differences between categorical variables (high 
alexithymia, sex and education level). The Bonferroni method was used to correct 
the p-value in multiple comparisons. Cohen’s d was used to describe effect sizes 
between alexithymia subtypes. Internal consistencies (Crohnbach’s alpha) were 
calculated for the TAS-20 as a whole, and for individual subscales (DIF, DDF and 
EOT). Sex, educational level and income were controlled for when analyzing 
associations with alexithymia levels, depression and anxiety symptoms, using 
hierarchical regression analysis. General Linear Model (GLM) was used for group 
comparisons to control for the same covariates. To uncover possible subtypes in 
alexithymia groups, a cluster analysis was conducted using the Ward’s method. The 
cluster analysis was conducted separately for high, moderate and low alexithymia 
groups.  
 Study II 
Normality of distribution was tested visually and with the Shapiro-Wilk test. TAS-
20, EPDS and SCL-90 scores were all non-normally distributed. Therefore, Mann-
Whitney U test was used to examine group differences in continuous outcome 
variables. Chi square test was used for categorical variables. In the intercorrelations 
between alexithymia scores and continuous outcome variables Spearman’s rho (ρ) 
was used to illustrate the strength of the association. Alcohol use was assessed at two 
different timepoints: In the first trimester of spouse’s pregnancy (T1), and 3 months 
after the baby was born (T2). Wilcoxon signed-rank test was used to assess changes 
in alcohol use from T1 to T2. Bonferroni method was used to correct for multiple 
comparisons. Hierarchical regression (alcohol use) and binomial logistic regression 
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(smoking status) analyses were conducted to examine associations between 
alexithymia dimensions and substance use, whilst controlling for age, educations 
level and concurrent anxiety symptoms. We chose anxiety symptoms as a covariate 
because it showed a slightly stronger association with alcohol use compared to 
depressive symptoms. To avoid multicollinearity, we did not include both as 
covariates. 
To better illustrate the relationship of EOT on substance abuse, we also used a 
categorical approach. As there is no established cut-off for high EOT scores, we 
compared the highest and lowest EOT quartile. To this end, we matched individuals 
in the highest (‘High EOT group’ N=173) and lowest (‘Low EOT group’ N=173) 
EOT quartile, using age, education level and anxiety scores as matching variables. 
Criteria for match was <4 years difference in age, <2 points difference in anxiety 
scores, and an exact match in education level. Case-control matching was conducted 
with the ‘Fuzzy’ extension of the SPSS. Cohen’s d was used to illustrate the effect 
sizes between groups. 
 Study III 
Normality of distribution was tested visually and using the Shapiro-Wilk test. TAS-
20, BMI and EPDS scores were all non-normally distributed. Thus, chi-square test 
was used to analyze categorical variables and Mann-Whitney U test for continuous 
variables. Kruskal-Wallis test was used for multiple group comparisons. Spearman’s 
rho (ρ) was used to quantify the strength of intercorrelations between variables. 
Bonferroni method was used to correct for multiple comparisons. Separate 
hierarchical regression analyses were conducted to examine associations between 
alexithymic traits and outcome variables, whilst controlling for the effects of age, 
education and current depressive symptoms at gestational week 34. Control variables 
were chosen based on the correlation analyses. Depressive symptoms were 
controlled for because depression commonly co-occurs with alexithymia and 
involves changes in appetite and weight. Control variables were entered in the 
hierarchical regression analysis in step 1, and alexithymia dimensions or overall 
TAS-20 score at step 2. For gestational diabetes, a binomial regression analysis was 
conducted using the same approach and covariates. For the regression analysis, BMI 
was transformed to its natural logarithm, after which residuals were normally 
distributed. As EOT explained the associations between alexithymia, BMI and 
gestational diabetes, we focused on this dimension in the subsequent group 
comparisons. As there is no established cut-off score for high EOT scores, we 
divided participants into quartiles by their EOT score. 
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 Study IV 
Normality of distribution within variables was tested visually and using the Shapiro-
Wilk test. Differences between categorical variables were analyzed with Chi Square 
test. Differences in hair cortisol concentrations (HCC) between alexithymia groups 
were analyzed using the Student’s t test. As BMI had a skewed distribution, Mann 
Whitney U test was used when analyzing group differences. An analysis of 
covariance (ANCOVA) was conducted to examine group differences between highly 
alexithymic individuals and controls, while controlling for potential confounders. 
Multiple regression analyses were conducted to examine the associations between 
alexithymia dimensions, overall alexithymia scores, and HCC, controlling for the 
effects of educational level, BMI and current depressive symptoms (EPDS) at 
gestational week 40. Natural logarithmic transformations were performed on the 
HCC data to reduce skewness. After transformation, HCC was normally distributed 
(Shapiro-Wilk test p>0.4 for both alexithymia groups). 
 Study V 
Normality of distribution within variables was tested visually and using the cut-off 
values of larger than 7 for kurtosis and larger than 2 for skewedness, indicating a 
non-normal distribution (Kim 2013). We did not use the Shapiro-Wilk test because 
it is overly sensitive to non-normality in large samples of data. All continuous 
predictor and outcome variables (TAS-20, EPDS, TADS dimensions and ECR-R) 
were non-normally distributed. TAS-20 scores and ECR-R scores were log-
transformed, after which they were normally distributed. Non-parametric tests were 
used when analyzing EPDS and SCL-90 scores because of high skewedness. Chi-
square test was used to assess group differences between categorical variables, and 
Student’s t test (for normally distributed data) or Mann-Whitney U test (for non-
normally distributed) between continuous variables. In the intercorrelations between 
maltreatment types, Spearman’s rho (ρ) (non-parametric) or Pearson’s r (parametric) 
was used to quantify the strength of the association. Analysis of Variance (ANOVA) 
was used to examine the association between education level and attachment 
security. When analyzing attachment insecurity in depression and alexithymia, 
General Linear Model (GLM) was used to control for sex, age and education level. 
GLM was additionally used when examining associations between non-
maltreatment types of EA, and alexithymia levels and depressive symptoms.  
To disentangle the specific impacts of CM types, individuals who reported a 
history of only one type of CM were compared to those who reported no 
maltreatment. As sexual abuse very rarely occurred alone, controlling for other types 
of CM was not possible, and therefore sexual abuse was left out of the final analyses. 
Binary logistic regression analysis was used to assess the impacts of non-
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maltreatment types of EA, whilst controlling for the effects of concurrent CM. Here, 
raw TADS total scores were used as a continuous control variable. As high 
alexithymia was rarer compared to current depression, the associations between CM 
types and alexithymia had wider confidence intervals. We therefore also analyzed 
associations of EA types, overall alexithymia scores, an scores of each alexithymia 
dimension separately, in order to avoid false negative conclusions concerning the 
relationship between EA types and alexithymia. 
4.6 Ethical Considerations 
The parents gave written informed consent on their own and on their child’s behalf. 
The children will be asked for personal consent at an appropriate age. The ethics 
Committee of the Hospital District of Southwest Finland has approved the study 
protocol.  
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5 Results 
5.1 Study I 
 Characteristics of the study sample 
Basic information and characteristics of the study sample is displayed in Table 1. 
Level of education and income were negatively associated with all outcome 
measures (EPDS, SCL-90 and TADS, p<0.01 for all comparisons). Women scored 
higher than men in depressive symptoms, but no differences between men and 
women were observed in SCL-90 anxiety score or TADS scores. Overall prevalence 
of high alexithymia was 2.8% in women and 6.0% in men. Mean ages in the low, 
moderate and high alexithymia groups were 32.0, 31.3 and 31.2 years respectively. 
Alexithymia scores had a weak negative association with age (ρ= −0.054, p=0.004). 
Moderate and high alexithymia groups had a lower education compared to the low 
alexithymia group (p<0.001, see Table 1), however, they did not differ in income 
level (p=0.131).  
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Table 1:  Comparisons of low, moderate and high alexithymia groups 
  Low 
alexithymia 
(N=2471) 
Moderate 
alexithymia 
(N=290) 
High 
alexithymia 
(N=113) 
All  
 
(N=2876) 
  N % N % N % N % 
Gender Female 
Male 
1662  
809 
67.3% 
32.7% 
167  
123  
57.6% 
42.4% 
52  
60  
46.4% 
53.6% 
1881  
992  
65.5% 
34.5% 
Education Low 
Mid 
High 
773  
721  
871  
32.7% 
30.5% 
36.8% 
142*  
67*  
69*  
51.1% 
24.1% 
24.8% 
59*  
27* 
22*  
54.6% 
25.0% 
20.4% 
974  
815  
962  
35.4% 
29.6% 
35.0% 
Income 
level 
<1000€/mo 
1000-2000€/mo 
2000-3000€/mo 
>3000€/mo 
382  
1052  
777  
150  
16.2% 
44.6% 
32.9% 
6.4% 
52  
130  
83  
13  
18.7% 
46.8% 
29.9% 
4.7% 
24  
43  
36  
4  
22.4% 
40.2% 
33.6% 
3.7% 
458  
1225  
896  
167  
16.7% 
44.6% 
32.6% 
6.1% 
MDD 
diagnosis 
 209  8.5% 42*  14.5% 21*  18.8% 272  9.5% 
Anxiety 
diagnosis 
 91  3.7% 19 6.6% 12* 10.7 % 122  4.2% 
  Median (IQR) Median (IQR) Median (IQR) Median (IQR) 
EPDS  3.0 (4.0)  6.0 (6.0) * 8.0 (8.0) * 3.0 (5.0) 
SCL-90  1.0 (3.0) 3.0 (7.8) * 5.3 (10.0) * 1.0 (4.0) 
TADS  6.0 (10.0) 11.0 (14.0) * 12.0 (14.3) * 7.0 (10.0) 
EPDS=depressive symptoms, SCL-90=anxiety symptoms, TADS =self-reported early life adversity, 
MDD diagnosis=lifetime diagnosed major depressive disorder, Anxiety diagnosis =lifetime 
diagnosed anxiety disorder. TAS-20 score under 52=low alexithymia, TAS-20 score 52–
60=moderate alexithymia, TAS-20 score over 60= high alexithymia. Education level: Low=high 
school or lower, Mid=applied sciences degree, High=university degree. Moderate alexithymia was 
compared to low alexithymia group, high alexithymia was compared to low/moderate group. *  p-
value<0.01. 
 Intercorrelations Between Alexithymia Dimensions 
DIF/DDF (ρ=0.563, p < 0.001) and DDF/EOT (ρ=0.394, p < 0.001) showed a 
moderate to strong positive correlation in the whole sample, whereas DIF/EOT 
(ρ=0.150, p<0.001) showed a mild positive correlation. However, analyzing 
moderate and high alexithymia groups separately, DIF and EOT had strong negative 
correlations (ρ= −0.701, p < 0.001 for moderate, and ρ= −0.513, p<0.001 for high 
alexithymia, see Fig. 1). In the low alexithymia group, DIF and EOT were not 
significantly correlated (ρ=0.020, p =0.311). 
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Figure 1:  Correlation between difficulty identifying feelings (DIF) (y-axis) and externally oriented 
thinking style (EOT) (x-axis) in different alexithymia groups. 
 The Relationship of Alexithymia and Psychopathology 
TAS-20 total scores were significantly associated with depressive symptoms 
(ρ=0.370, p < 0.001), anxiety symptoms (ρ=0.308, p<0.001), and self-reported early 
life adversity (ρ=0.203, p < 0.001). DIF showed the strongest, and EOT the weakest 
correlation with psychiatric symptoms. EOT also showed a mild negative correlation 
with early-life adversity (ρ= −0.069, p<0.001). Individuals with high alexithymia 
more frequently reported having been diagnosed with MDD (18.6% vs. 9.1%; 
p=0.003) and anxiety disorder (10.6% vs. 4.0%; p =0.003) compared to those with 
low or moderate levels of alexithymia. 
 Cluster Analyses 
To uncover possible subtypes of alexithymia, we first conducted a cluster analysis 
in the high alexithymia group. A two-cluster solution showed the best fit, as indicated 
by the largest change in the agglomeration coefficient in the last step of the cluster 
analysis. We will call these clusters Type A (TA) and Type B (TB) alexithymia. TA 
was characterized by significantly higher scores in DDF and EOT, while TB scored 
higher in the subscale DIF. The most distinct differences between TA and TB were 
seen in DIF and EOT (Table 2). Importantly, there were no significant differences in 
alexithymia total scores between the two subtypes (median scores 64.0 in both 
clusters; p=0.639). 
We replicated the cluster analyses in the moderate- and low alexithymia groups 
separately. In both cases, a similar two-cluster model emerged. Specifically, in both 
groups there was one cluster with higher DIF scores, and another cluster with higher 
EOT scores. As there were differences in the gender distribution among the clusters, 
we also replicated the cluster analyses in men and women separately. These analyses 
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also produced two clusters with similar patterns of alexithymia levels and psychiatric 
symptoms.  
Table 2:  Differences Between Alexithymia Clusters 
  
Type A 
alexithymia 
(N=60) 
Type B 
alexithymia 
(N=53) 
All  
 
(N=2876) 
Gender Female 36.7% 58.5% 65.4% Male 63.3% 41.5% 34.6% 
TAS-20 total Item mean (SD) 3.3 (0.2) 3.2 (0.2) 2.0 (0.5) 
DIF Item mean (SD) 2.7 (0.4) 3.4 (0.3) * 1.6 (0.6) 
DDF Item mean (SD) 3.8 (0.5) 3.5 (0.5) * 1.9 (0.7) 
EOT Item mean (SD) 3.4 (0.3) 2.9 (0.3) * 2.4 (0.5) 
TAS-20=Alexithymia total score, DIF=Difficulty identifying feelings, DDF=Difficulty describing 
feelings, EOT=Externally oriented thinking style.TAS-20 score under 52=Low alexithymia, TAS-20 
score 52-60=Moderate alexithymia, TAS-20 score over 60=High alexithymia. * p<0.01 (cluster A 
vs. B) 
Comparing the two alexithymia subtypes showed that TB scored higher in EPDS 
(effect size comparing TA and TB alexithymia d=0.77), SCL-90 anxiety scale 
(d=0.82) and TADS (d=0.42) compared to TA (Table 3). The TB group also reported 
a higher prevalence of MDD and anxiety disorders (Table 3). Similarly, both in the 
moderate- and low alexithymia groups, cluster B scored higher in EPDS, SCL-90 
anxiety scale, and TADS scores. As education, income and sex were significant 
predictors of psychiatric outcomes, we tested whether differences in these variables 
explained the group differences between alexithymia subtypes. However, the general 
linear model showed that group differences remained significant after controlling for 
these factors (p < 0.001 for EPDS and SCL-90, p=0.030 for TADS). 
Table 3:  Alexithymia Subtypes: Differences in Psychopathology and Early-life Adversity 
  
Type A 
alexithymia (A) 
(N=60) 
Type B  
alexithymia (B) 
(N=53) 
p  
(A vs. B) 
Low/moderate 
alexithymia (C) 
(N=2763) 
EPDS Median (IQR) 6.0 (7.0) 11.0 (8.0) <0.0011 3.0 (5.0) 
SCL-90 Median (IQR) 3.75 (8.0) 8.0 (13.0) <0.0011 1.0 (4.0) 
TADS Median (IQR) 10.0 (12.25) 15.0 (17.0) <0.051 6.0 (11.0) 
MDD 
diagnosis N (%) 5 (8.3%) 16 (30.2%) <0.01
2 251 (9.1%) 
Anxiety 
diagnosis N (%) 2 (3.3%) 10 (18.9%) <0.01
2 110 (4.0%) 
EPDS=Depressive symptoms, SCL-90=Anxiety symptoms, TADS=Self-reported early life 
adversity, MDD diagnosis=Lifetime diagnosed major depressive disorder, Anxiety 
diagnosis=Lifetime diagnosed anxiety disorder. TAS-20 score under 52=Low alexithymia, TAS-20 
score 52-60=Moderate alexithymia, TAS-20 score over 60=High alexithymia. 1=Mann-Whitney U 
test, 2=Chi square test 
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5.2 Study II 
 Study Population and Correlations Between Variables 
Demographic information, substance use and alexithymia levels of the study sample 
are displayed in Table 4. Age and education were both positively associated with 
frequency of alcohol use (ρ=0.088, p=0.008 and ρ=0.071, p < 0.033 respectively), 
but lower quantity per occasion (ρ= −0.146, p < 0.001 and ρ=0.136, p < 0.001 
respectively). Both SCL-90 anxiety scale and EPDS showed positive associations 
with frequency of alcohol use in T2 (ρ=0.070, p=0.035 for EPDS and ρ=0.094, 
p=0.005 for SCL-90), but not in T1. Neither SCL-90 anxiety scale nor EPDS were 
associated with quantity of alcohol per occasion. DIF, DDF or TAS-20 overall scores 
were not associated with any measure of alcohol use (p>0.2 for all comparisons). 
EOT showed a weak correlation with alcohol quantity both in T1 (ρ=0.103, p=0.008) 
and T2 (ρ=0.095, p=0.020), but was not related to frequency of alcohol use (p>0.2 
in both timepoints).  
Prevalence of daily smoking was 13.9%. Smoking status was associated with 
lower age, lower education and higher EOT (p<0.001 for all comparisons), as well 
as higher TAS-20 overall scores (p=0.004), but not DIF or DDF (p>0.1 for both 
comparisons). Daily smoking was also related to higher depression and anxiety 
scores in T1 (p<0.01 for both comparisons) but not T2 (p>0.1 for both comparisons). 
Both the frequency and quantity of alcohol use declined from T1 to T2. 
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Table 4:  Demographic information on the total sample, and group differences between 
matched individuals with high vs. low EOT scores. 
 
 
Whole 
sample 
Lower 
quartile 
EOT 
Upper 
quartile 
EOT 
p (lower 
vs. upper 
quartile) 
Education 
1. 
2. 
3. 
4. 
5. 
 
 
36 (3.6%) 
256 (25.8%) 
103 (10.4%) 
310 (31.2%) 
237 (23.8%) 
 
4 (2.3%) 
34 (19.7%) 
20 (11.6) 
74 (42.8%) 
41 (23.7%) 
 
4 (2.3%) 
34 (19.7%) 
20 (11.6) 
74 (42.8%) 
41 (23.7%) 
 
 
 
N/A 
Age (SD) 33.1 (5.4) 33.3 (4.6) 33.1 (4.7) 0.381a 
EPDS mean (SD) 3.5 (3.3) 3.4 (3.5) 3.7 (3.2) 0.201 a 
SCL-90 mean (SD) 2.3 (3.3) 2.3 (2.8) 2.1 (3.2) 0.055a 
DIF mean (SD) 1.6 (0.6) 1.4 (0.5) 1.7 (0.7) <0.001a 
DDF mean (SD) 2.2 (0.8) 1.8 (0.7) 2.5 (0.8) <0.001a 
EOT mean (SD) 2.6 (0.6) 1.9 (0.3) 3.3 (0.3) <0.001a 
TAS-20 mean (SD) 2.2 (0.5) 1.7 (0.3) 2.5 (0.4) <0.001a 
Alcohol quantity* mean T1 (SD) 3.6 (3.7) 2.9 (2.7) 4.8 (5.6) <0.001a 
Alcohol quantity* mean T2 (SD) 2.7 (2.6) 2.3 (2.4) 3.1 (2.9) 0.012a 
Alcohol frequency T1 
Never 
Less than monthly 
1-2 times per month 
Weekly 
Many times a week 
Daily 
 
70 (7.0%) 
113 (11.4%) 
339 (34.1%) 
339 (34.1%) 
106 (10.7%) 
5 (0.5%) 
 
19 (11.4%) 
17 (10.2%) 
44 (26.3%) 
65 (38.9%) 
22 (13.2%) 
0 (0.0%) 
 
11 (6.7%) 
31 (19.0%) 
44 (27.0%) 
57 (35.0%) 
20 (12.3%) 
0 (0.0%) 
 
 
0.495 a 
Alcohol frequency T2 
Never 
Less than monthly 
1-2 times per month 
Weekly 
Many times a week 
Daily 
 
75 (8.3%) 
142 (15.7%) 
305 (33.8%) 
326 (26.1%) 
52 (5.8%) 
3 (0.3%) 
 
16 (9.3%) 
26 (15.1%) 
62 (36.0%) 
57 (33.1%) 
11 (6.4%) 
0 (0.0%) 
 
15 (8.8%) 
39 (22.8%) 
59 (34.5%) 
52 (30.4%) 
6 (3.5%) 
0 (0.0%) 
 
 
0.152 a 
Cigarettes smoked per day (SD) 11.1 (6.4) 9.7 (7.2) 13.0 (6.2) 0.051 a 
Education: 1. High school or lower 2. Vocational degree 3. Upper secondary school degree 4. 
Applied sciences or bachelor’s degree 5. University degree. DIF=Difficulty Identifying Feelings. DDF 
= Difficulty Describing Feelings. EOT=Externally Oriented Thinking Style. TAS-20=alexithymia total 
scores. EPDS = depressive symptoms. SCL-90=anxiety symptoms. *Alcohol quantity=Amount of 
alcohol consumed per occasion in standard doses of 12g of ethanol. T1=gestational week 14, T2=3 
months after participant’s baby was born. a=Mann-Whitney U test. 
 Regression analyses 
After controlling for the effects of age, education level and current anxiety 
symptoms, EOT remained significantly associated with alcohol quantity both at T1 
(B=0.011, F change=4.330, p=0.038) and at T2 (B=0.009, F change=3.992, 
p=0.046). DIF, DDF or TAS-20 total scores did not explain any variance in alcohol 
quantity (p > 0.05 for all tests). Frequency of alcohol use was not related to any 
alexithymia dimension, or total alexithymia level. In the binomial regression 
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analysis, smoking status was not associated with alexithymia levels or individual 
dimensions (p > 0.05 for all tests). 
 Group Comparisons 
Group comparisons between matched individuals from the high and low EOT groups 
are shown in Table 4. The high EOT group consumed more alcohol per occasion at 
T1 (Cohen’s d 0.43, p<0.001) and T2 (Cohen’s d 0.30, p<0.012), and were more 
often daily smokers (8.7% vs. 17.3%, p=0.023, Figure 2) compared to the low EOT 
group. The high EOT group also reported more binge drinking (drinking five or more 
doses of alcohol per occasion, 23.7% vs 41.6%, p=0.001) compared to the low EOT 
group. The groups did not differ in frequency of alcohol use in either timepoint. 
 
Figure 2:  Prevalence of binge drinking (either timepoint T1 or T2) and daily smoking between high 
and low EOT groups. Binge drinking: 5 or more doses of alcohol consumed per 
occasion. 
5.3 Study III 
 Study Population and Correlations Between Variables 
Characteristics of the study sample and differences between alexithymia groups are 
shown in Table 5. 35.6% (N=591) of participants were overweight and 16.7% 
(N=278) fulfilled the criteria for gestational diabetes. 2.8% (N=46) of the 
participants scored high, and 9.1% (N=151) moderately high in alexithymia. EPDS 
total scores (ρ=0.01, p=0.62) in gestational week 34, as well as DIF (ρ= -0.003, 
p=0.88) and DDF (ρ=0.027, p=0.243), were unrelated to BMI in the correlation 
analyses. TAS-20 total scores showed a weak positive correlation with BMI 
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(ρ=0.058, p=0.01), but the association was entirely explained by the EOT subscale 
(ρ=0.103, p<0.001). 
Those fulfilling the criteria for gestational diabetes had a higher BMI (24.0 vs. 
27.9, p<0.001) as well as higher scores in EOT (18.5 vs. 19.2, p=0.006) compared 
to those with normal glucose levels. Gestational diabetes was not associated with 
EPDS scores (4.7 vs. 4.7, p=0.74), DIF (11.6 vs. 11.7, p=0.97), DDF (9.6 vs. 9.6, 
p=0.93) or TAS-20 total scores (39.6 vs. 40.5, p=0.16). 
Table 5:  Demographic information on the total sample, and group differences between 
alexithymia groups 
Education: Low=High school or lower. Mid=Vocational / upper secondary school degree. 
High=Applied sciences or university degree. BMI=Body Mass Index. Overweight = BMI ≥25 EPDS 
= Edinburgh Postnatal Depression Scale. TAS-20=Alexithymia total score. a=Chi square test, 
b=Kruskal Wallis test. 
 Regression analyses 
After controlling for the selected confounders (age, education, EPDS scores), the 
overall level of alexithymia (β=0.080, p=0.002, R2=0.006) as well as the EOT 
dimension (β=0.085, p=0.001, R2=0.007) remained significantly associated with 
BMI. Binomial logistic regression showed that the overall level of alexithymia 
(Exp(B) 1.015, CI95% 1.001-1.030, p=0.041), as well as EOT (Exp(B) 1.041, 
CI95% 1.009-1.073, p=0.011) were also independently associated with gestational 
diabetes. DIF and DDF had no relationship to either outcome variable (p>0.1 for all 
tests). 
 Low 
alexithymia 
(N=1462) 
Moderate 
alexithymia 
(N=151) 
High 
alexithymia 
(N=46) 
Whole 
sample 
(N=1660) 
p (difference 
between 
groups) 
Education 
Low 
Mid 
High 
 
4.9% 
28.9% 
66.1% 
 
8.6% 
43.0% 
48.3% 
 
6.4% 
48.9% 
44.7% 
 
5.3% 
30.8% 
63.9% 
 
 
<0.001 a 
 
 Mean (SD)     
Age in years 31.2 (4.3) 30.2 (4.6) 30.3 (4.3) 31.1 (4.4) 0.02 b  
BMI 24.6 (4.7) 25.0 (5.5) 26.7 (5.2) 24.7 (4.8) 0.006 b  
EPDS 4.3 (3.7) 6.7 (4.3) 8.8 (5.1) 4.7 (4.0) <0.001 b  
TAS-20 37.5 (6.7) 55.2 (2.5) 64.7 (4.3) 39.9 (9.3) <0.001 b  
 Prevalence (%)     
Primiparous 55.1% 42.5% 52.3% 53.9% 0.014 a 
Overweight 34.8% 34.7% 66.0% 35.7% <0.001 a  
Gestational 
diabetes 
16.6% 15.9% 25.5% 16.7% 0.26 a  
Jani Kajanoja 
 60
 Group Comparisons 
High alexithymia (TAS-20 total score > 60) was associated with a higher BMI (26.7 
vs. 24.7, p=0.001) and a higher prevalence of overweight [(66.0% vs. 34.8%, OR 
(unadjusted)=3.6 , OR (adjusted)=3.6, CI95% 1.9-6.8, p<0.001)] compared to 
low/moderate levels of alexithymia. Differences in the prevalence of gestational 
diabetes was not significant (25.5% in high alexithymia group, 16.5% in controls, 
p=0.102). 
To better illustrate the impact of EOT on overweight and gestational diabetes, 
we divided participants into quartiles by EOT scores, and compared the highest and 
lowest quartiles. Between the lowest and highest EOT quartile, the adjusted odds 
ratio for overweight was 1.94 [CI95% 1.43-2.62, p<0.001]; and for gestational 
diabetes 1.75 [CI95% 1.19-2.58, p=0.005]. (Figure 3). 
 
Figure 3:  Prevalence of overweight and gestational diabetes by EOT quartile. EOT=Externally 
Oriented Thinking Style. 
5.4 Study IV 
Demographic information of the study sample, as well as differences between 
alexithymia groups are shown in Table 6. Reported substance use among the 
participants was negligible: Only one participant in each group reported tobacco use 
after the first trimester of pregnancy. There was no significant difference in alcohol 
use between alexithymia groups (7.7% vs 8.3%). Frequency of alcohol use in all 
cases was less than once a month, and ≤ 1 standard dose of alcohol per occasion. No 
participants reported current illegal drug use. 
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Table 6:  Basic information and comparison of hair cortisol concentrations between 
alexithymia groups 
 No alexithymia 
(N=118) 
Moderate to high 
alexithymia (N=12) 
 
test statistic 
 
p 
     
Level of education*  
1. 
2. 
3. 
4. 
5. 
 
0% 
9.6% 
9.6% 
37.4% 
43.5% 
 
16.7% 
25.0% 
8.3% 
25.0% 
25.0% 
 
 
 
-2.257b 
 
 
 
0.024 
 
 
Age 
 
Mean (SD) 
31.6 (3.7) 
 
Mean (SD) 
30.2 (4.6) 
 
 
1.24a 
 
 
0.217 
Depressive symptoms 4.3 (3.9) 7.3 (3.9) -2.55b 0.011 
BMI 24.2 (27.6) 27.6 (7.2) -1.68b 0.094 
HCC (pg/ml) 17.8 (19.3) 35.1 (31.5) -2.73a 0.007 
DIF 11.2 (3.6) 20.8 (4.3) -5.22b <0.001 
DDF 9.2 (3.0) 16.4 (3.4) -5.12b <0.001 
EOT 17.7 (4.3) 22.0 (3.4) -3.21b <0.001 
TAS-20 total 38.0 (7.2) 59.2 (5.8) -5.67b <0.001 
a Student’s t test, b Mann Whitney U test. HCC=Hair cortisol concentrations. BMI=Body mass index 
DIF=Difficulty Identifying Feelings, DDF=Difficulty Describing Feelings, EOT=Externally Oriented 
Thinking. *Level of education: 1. High school or lower; 2. Vocational degree; 3. Upper secondary 
school; 4. Applied sciences or bachelor’s degree; 5. Graduate school or PhD degree. 
As shown in Table 6, the moderate/high alexithymia group had higher levels of HCC. 
This difference stayed significant after controlling for the potential confounders 
(F=5.11, partial η² 0.040, p=0.026). Removing two participants who reported current 
SSRI/SNRI use during pregnancy slightly strengthened the group difference 
(F=6.12, partial η² 0.049, p=0.015). Additionally removing one participant who 
reported SSRI/SNRI only in the first trimester, and five participants who reported 
glucocorticoid use during pregnancy, did not affect the results. 
As most participants had low levels of alexithymia, we also analyzed the linear 
association of alexithymia levels and HCC in the whole sample. As EPDS scores 
were not associated with HCC, they were removed from covariates at this stage. In 
the regression analysis, DIF remained significantly associated with HCC (Table 7). 
Other alexithymia dimensions or overall scores were not significantly associated 
with HCC (p>0.1 for all tests). Additionally, education level and BMI were 
negatively associated with HCC (Table 7). 
Jani Kajanoja 
 62
Table 7:  Summary of multiple regression analysis of variables predicting hair cortisol 
concentration 
 B Standard error β t p 
Body mass index -.045 .017 -.243 -2.668 .009 
Level of education -.213 .080 -.234 -2.667 .009 
DIF .039 .019 .187 2.064 .041 
DIF=Difficulty Identifying Feelings 
5.5 Study V 
 Study Sample 
Demographic information on the study sample, as well as prevalences of EA types 
are shown in Table 8. All types of CM were associated with lower education (p<0.02 
for all). Raw scores of CM types were highly intercorrelated (ρ=0.489 – 0.641, 
p<0.001 for all). The strongest associations were between emotional abuse and 
emotional neglect (ρ=0.641, p<0.001), and as well as emotional neglect and physical 
neglect (ρ=0.637, p<0.001). Non-maltreatment types of EA were also all associated 
with every type of CM (p<0.005 for all). 
43.5% (N=1128) of participants reported no history of childhood maltreatment. 
5.7% (N=148) reported only emotional neglect. 9.1% (N=236) only physical neglect, 
2.8% (N=72) only emotional abuse, 2.1% (N=55) only physical abuse, and 0.6% 
(N=16) only sexual abuse. 
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Table 8:  Demographic information and prevalence of different types of early-life adversity 
 Men (N=882) Women (N=1713) Whole sample (N=2595) 
 
Level of education 
 
1. 4.1% 
2. 39.2% 
3. 56.7% 
 
1. 2.0% 
2. 30.6% 
3. 67.4% 
 
1. 2.7% * 
2. 33.5% 
3. 63.8% 
  
Mean (SD) 
  
Age 32.8 (5.3) 31.2 (4.3) 31.8 (4.8) * 
TAS-20 score 43.0 (9.7) 39.7 (9.3) 40.9 (9.5) * 
ECR-R anxiety 2.2 (0.8) 2.4 (0.9) 2.3 (0.9) * 
ECR-R avoidance 2.5 (0.8) 2.3 (0.8) 2.4 (0.8) * 
  
Median [IQR] 
  
EPDS score 2.0 [4.0] 4.0 [6.0] 3.0 [5.0] * 
  
Prevalence (%) 
  
Current depression 7.8% 15.9% 13.2% * 
High alexithymia 6.2% 2.7% 5.4% * 
 
Emotional neglect 
 
34.7% 
 
34.9% 
 
34.8% 
Emotional abuse 22.7% 31.1% 28.2% * 
Physical abuse 21.1% 22.2% 21.8% 
Physical neglect 38.7% 36.9% 37.5% 
Sexual abuse 1.7% 4.6% 3.6% * 
 
Parental separation 
 
22.6% 
 
25.2% 
 
24.3% 
Parental financial problems 10.9% 16.1% 14.3% * 
Parental psychiatric disorder 9.2% 15.2% 13.2% * 
Parental substance abuse 13.4% 19.7% 17.5% * 
Level of education: 1. High school or lower; 2. Vocational / upper secondary school degree; 3. 
Applied sciences / University degree. TAS-20=Toronto Alexithymia Scale, EPDS=Edinburgh 
Postnatal Depression Scale, ECR-R=Experiences in Close Relationships. * Significant difference 
between men and women (p<0.05). 
 Impacts of specific types of EA on depression and 
alexithymia 
Figure 4 shows the specific contributions of each EA type on current depression and 
alexithymia. 65.3% of participants scoring high in alexithymia reported a history of 
emotional neglect compared to 33.6% of those with low or moderate alexithymia 
levels (p<0.001). 
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Figure 4:  Associations of specific types of early-life adversity (EA) with depression and 
alexithymia. OR=Odds Ratio, LCL=Lower limit for 95% confidence interval UCL=Upper 
limit for 95% confidence interval. For each type of childhood maltreatment (CM), history 
of other types of CM has been excluded. For non-maltreatment types of EA, adjusted 
ORs are displayed, after controlling for the effects of concurrent CM. Graph created by 
Forest Plot Generator by Evidence Partners. 
Analyzing alexithymia levels as continuous variables showed that emotional neglect 
was the strongest predictor of all alexithymia dimensions and overall scores (t=3.237 
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for DIF, t=4.328 for DDF, t=4.915 for EOT, t=5.9 for total scores, p<0.001 for all 
comparisons). Additionally, emotional abuse was weakly related to DIF (t=2.307, 
p=0.021) and physical neglect was weakly related to EOT (t=2.2, p=0.029). 
All non-maltreatment types of EA were unrelated to overall alexithymia levels 
after controlling for the effects of CM. Regarding individual alexithymia 
dimensions, after controlling for CM, parental substance abuse was positively 
associated with DIF, whereas parental psychiatric disorders and substance use were 
both negatively associated with EOT, but the effect sizes were small (F=7.45, 
p=0.006, partial ŋ2=0.003 for substance abuse and DIF), (F=23.70, p<0.001, partial 
ŋ2=0.009 for psychiatric disorder and EOT), (F=4.69, p=0.03, partial ŋ2=0.002 for 
substance abuse and EOT) 
As alexithymia, depression and some types of EA where unevenly distributed 
among men and women, we also investigated if the associations between EA and 
outcome variables were gender-specific. Emotional neglect was significantly 
associated with overall alexithymia levels in both men and women (t=3.1, p=0.002 
for men, t=4.5, p<0.001 for women). Parental financial problems (F=7.5, partial 
ŋ2=0.004, p=0.006) and substance abuse (F=6.1, partial ŋ2=0.004, p=0.014) showed 
a positive association with overall alexithymia levels in women, but not in men. 
Other types of EA had no gender-specific effects on alexithymia levels. However, 
for women several types of EA were associated with depressive symptoms (parental 
psychiatric disorders, financial problems, emotional neglect and emotional abuse), 
whereas in men emotional neglect was the only predictor of depressive symptoms.  
 Adult Attachment 
Women scored higher in attachment anxiety (2.41 vs. 2.23, t=4.81, p<0.001), 
whereas men scored higher in attachment avoidance (2.34 vs. 2.49, t=4.33, p<0.001). 
Depressive symptoms and alexithymia levels were both positively correlated with 
attachment anxiety (ρ=0.343, p<0.001 for EPDS; ρ=0.329, p<0.001 for TAS-20) and 
avoidance (ρ=0.179, p<0.001 for EPDS; ρ=0.379, p<0.001 for TAS-20). After 
controlling for potential confounders, attachment anxiety was most strongly related 
to depressive symptoms, while attachment avoidance was more strongly related to 
alexithymia levels (Table 9). 
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Table 9:  Results of the General Linear Model Predicting Depressive Symptoms and 
Alexithymia Levels 
 EPDS    TAS-20   
 F p Partial η2  F p Partial η2 
        
Sex 35.74 <0.001 0.014  82.09 <0.001 0.031 
Age 2.44 0.118 0.001  31.99 <0.001 0.012 
Education 4.05 0.044 0.002  34.45 <0.001 0.013 
ECR-R anx 214.72 <0.001 0.077  116.20 <0.001 0.043 
ECR-R av 4.28 0.039 0.002  194.77 <0.001 0.070 
Full model 78.32 <0.001 0.131  151.66 <0.001 0.227 
EPDS=Edinburgh Postnatal Depression Scale; TAS-20=Toronto Alexithymia Scale; ECR-R 
anx=Attachment Anxiety; ECR-R av=Attachment Avoidance 
 Depression with and Without Alexithymia 
Depressive symptoms and alexithymia levels were moderately correlated (ρ=0.367, 
p<0.001). 14% (N=48) of depressed participants had high levels of alexithymia. 
30.4% of depressed men were highly alexithymic compared to 9.9% of depressed 
women (p<0.001). Of depressed individuals with high alexithymia, 81.3% reported 
a history of childhood emotional neglect, compared to 54.4% of those with low or 
moderate levels of alexithymia (p<0.001). Depression with alexithymia associated 
with higher levels of attachment anxiety (mean scores 3.20 vs. 2.84, t=2.38, p=0.018) 
and attachment avoidance (mean scores 3.03 vs. 2.52, t=4.03, p<0.001) compared to 
depression without alexithymia. 
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6 Discussion 
6.1 Alexithymia subtypes (Study I) 
In light of previous research, this study aimed to confirm the existence of alexithymia 
subtypes, and to illuminate their differences in terms of psychiatric symptoms using 
a cluster analytical approach. We identified two clusters (subtypes) of alexithymia: 
Type A alexithymia (TA) was characterized by high scores in externally oriented 
thinking and was more prevalent in men compared to women. Type B alexithymia 
(TB) was in turn characterized by high scores in DIF, was more equally distributed 
among genders, associated with increased depressive and anxiety symptoms, and 
those with it more frequently reported a history of diagnosed Major Depression and 
anxiety disorders. Replicating the cluster analysis in the moderate- and low 
alexithymia groups produced similar clusters. Specifically, higher DIF, but not EOT, 
was related to higher levels of psychiatric symptoms, regardless of the overall 
alexithymia score. This supports the view of alexithymia as a heterogeneous and 
dimensional construct. Therefore, it may be problematic that many studies examine 
alexithymia as a unidimensional and categorical outcome. 
Our results are partially similar to a cluster analytical study by Chen et al. (2011) 
in a Chinese sample of students. This study also found separate alexithymia groups 
scoring high in DIF and EOT. Furthermore, those with high DIF scored higher in 
depressive and anxiety symptoms and used more suppressive emotion regulation 
strategies compared to those with only high EOT. However, the results may not be 
directly comparable as most participants in this study showed high levels of EOT.  
When analyzing intercorrelations between alexithymia dimensions in the whole 
sample, DIF, DDF and EOT showed moderately positive correlations. Interestingly, 
when examining their correlations in the moderate- and high alexithymia groups 
separately, DIF and EOT showed moderate to strong negative correlations. This is a 
new finding and supports the results of our cluster analyses, implying that individuals 
with higher alexithymia levels tend to divide into two groups, scoring high either in 
DIF or EOT. In other words, individuals who score high in EOT do not report 
subjective difficulties in identifying feelings. This is somewhat puzzling, as EOT has 
been found to negatively associate with e.g. emotional intelligence (Parker et al. 
2001). Alkan Härtwig et al. (2014) have previously reported similar findings, 
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showing that individuals with high alexithymia who score high in DIF but not in 
EOT, exhibit more psychological distress compared to those with high scores in both 
DIF and EOT. They hypothesized that EOT may serve as a protective trait in 
alexithymia, buffering the effects of psychological distress. Our results support this 
hypothesis. It could be that some alexithymic individuals (TA) may develop a 
disinterest in emotions, perhaps protecting them from depression and anxiety. 
Interestingly, this phenotype was more common in men. However, it is unclear 
whether EOT offers any ‘real’ protective value, as it could be that the type A 
alexithymia group is simply less prone to reporting psychiatric symptoms. EOT is 
characterized by a lower tendency and interest in introspection, fantasy, and 
emotional content. Therefore, it is possible that individuals scoring high in EOT also 
have a deficit in emotional processing, but they may not easily recognize or admit 
this as a problem.  
Ueno et al. (2014) also analyzed alexithymia subtypes based on the Big-5 
personality features. They identified two subtypes: The first was characterized by 
high scores in DIF and neuroticism, the other by high scores in EOT and low scores 
in openness to experience. The authors hypothesized that high scores in DIF may not 
represent ‘true’ alexithymia, as these individuals are at least to some extent aware of 
their difficulties in identifying feelings and exhibit negative affect. EOT on the other 
hand, as it associates with low openness to experience, may instead characterize the 
construct alexithymia more accurately. Indeed, some evidence has shown that 
particularly the EOT dimension of alexithymia may modulate attention allocation 
and physiological responses to affective stimuli (Davydov et al. 2013; Wiebe et al. 
2017). Therefore, future studies should address these subtypes of alexithymia, and 
examine how individual alexithymia dimensions contribute to objective markers of 
stress, affective functioning, and more diverse outcomes of psychopathology, 
including externalizing behaviors and addictive disorders. 
6.2 The impact of alexithymia on men’s alcohol 
and tobacco use (Study II) 
Previous studies have reported a consistently high prevalence of alexithymia in 
patient populations with alcohol and substance abuse (see section 2.7.4). However, 
fewer studies have focused on the relationship of alexithymia and substance use in 
healthier populations. We examined the role of alexithymia dimensions in men’s 
alcohol and tobacco use. Previous research implies that individuals with substance 
abuse disorders show high levels of alexithymia. Our results suggest that at least in 
men, the EOT dimension of alexithymia may be of particular importance associating 
with patterns of substance use. High levels of EOT independently associated with 
quantity of alcohol use per occasions, as well as daily smoking. Overall alexithymia 
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levels, as well as DIF and DDF were unrelated to substance use levels. Comparing 
the matched groups of high and low EOT showed that individuals with high EOT 
were nearly twice as likely to report binge drinking and daily smoking compared to 
the low EOT group. 
Our findings add knowledge into the role of individual alexithymia dimensions 
in mental health. Previous research consistently shows that while DIF and DDF 
strongly associate with depressive and anxiety symptoms, EOT does not (Grabe et 
al. 2004; Chen et al. 2011; Kajanoja et al. 2017). It has even been speculated that 
EOT could serve as a protective factor in alexithymic individuals. However, we 
argue that the issue is likely to be more complex than that. Recently, Preece et al. 
have suggested that DIF/DDF and EOT may represent problems in different phases 
of emotion regulation. Their attention-appraisal model of alexithymia holds that 
DIF/DDF may constitute a difficulty in the conscious appraisal of emotional 
information (distinguishing the meaning and significance of emotional information), 
whereas EOT could arise from a deficit in the attentional phase (less attention 
allocated to emotional content and stimuli) (Preece et al. 2017). Our findings, as well 
as previous research on alexithymia subtypes may support the attention-appraisal 
model, as DIF/DDF and EOT seem to be associated with different risk profiles in 
terms of mental health (Chen et al. 2011; Alkan Härtwig et al. 2013; Ueno et al. 
2014; Kajanoja et al. 2017). Specifically, inattention and disinterest in emotional 
information as characterized by EOT, may protect those with alexithymia from 
depression and anxiety, but instead predispose them to regulate emotions by 
substance use, and perhaps other externalizing behaviors.  
6.3 Alexithymia, Overweight and Gestational 
Diabetes in Pregnant Women (Study III) 
We examined associations between alexithymia levels, BMI and gestational diabetes 
in pregnant women. The main finding of this study was that expecting mothers with 
high levels of alexithymia had a markedly higher BMI, and an increased prevalence 
of overweight (66% vs. 34.8%) compared to those with low or moderate levels of 
alexithymia. Several previous studies have similarly associated alexithymia with 
overweight, obesity and metabolic problems (see section 2.7.5). However, most have 
not differentiated between alexithymia dimensions. We found that the alexithymia 
dimension EOT accounted for the associations between alexithymia and BMI. EOT 
was also the only dimension of alexithymia that was associated with an increased 
prevalence of gestational diabetes. This is an important finding because EOT, as 
opposed to the affective component of alexithymia (DIF & DDF) is usually unrelated 
to depressive and anxiety symptoms, as was the case in our study. Therefore, the 
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association between EOT, BMI and gestational diabetes seems to be independent of 
mood and anxiety. 
The results are partially in line with previous studies. In the study by Fukunishi 
& Kaji (1997), EOT was also the only alexithymia factor related to obesity. In 
contrast, other studies have reported that all alexithymia dimensions, or only DIF 
and DDF have been associated with obesity (Elfhag & Lundh 2007; Pinna et al. 
2011). One explanation for this discrepancy might be that our study sample was 
relatively healthy, and we measured overweight instead of obesity, as only few 
individuals in our sample met the criteria for obesity. For example, in the study 
sample of Elfhag & Lundh (2007), the average BMI was higher than in our study, 
and a number of participants fulfilled the criteria for binge-eating disorder, which 
was most strongly correlated with the alexithymia dimension DIF. 
Several possible mechanisms could explain the link between alexithymia, 
overweight and gestational diabetes. As reviewed in section 2.7.5, alexithymia 
associates with an unhealthier diet and emotional eating which both promote weight 
gain. For example, Pink et al. (2019) recently found that DIF and DDF were 
associated with a higher BMI, and the relationship was largely mediated by negative 
affect and emotional eating. There was also an association between EOT and higher 
BMI, but instead of emotional eating, it was mediated by negative urgency. This is 
logical given that EOT is not associated with negative affect. Chronic stress could 
also contribute to the dietary habits and metabolic problems in alexithymia. Chronic 
stress is an important risk factor for several addictive behaviors and is associated 
with unhealthier and more energy-dense food choices leading to weight gain 
(Dallman 2010; Sinha 2018). 
Our results are especially interesting because they share parallels with the 
concepts of internalizing and externalizing problems: The alexithymia dimensions 
DIF and DDF are strongly correlated with negative affect and an increased 
prevalence of depression and anxiety disorders, suggesting that DIF and DDF could 
be conceptualized as internalizing traits. EOT on the other hand seems to have no 
effects on mood or anxiety, but instead seems to associate with lower empathy 
(Grynberg et al. 2010), increased substance use (Kajanoja et al. 2018) and primary 
psychopathic traits (Lander et al. 2012), reflecting an externalizing trait. Therefore, 
it could be that the individual alexithymia dimensions may contribute to overweight 
by different pathways. As implied by the results of Pink et al. (2019), individuals 
with difficulties in the affective dimension of alexithymia (DIF & DDF) may be 
more prone to emotional eating due to negative affect. The positive association 
between EOT and negative urgency on the other hand implies that EOT may 
predispose to externalizing behaviors such as addictive use of substances and 
possibly food. 
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6.4 Alexithymia and hair cortisol concentrations in 
pregnant women (Study IV) 
We found that pregnant women with moderate to high alexithymia levels had higher 
hair cortisol concentrations compared to those with low levels of alexithymia. 
Additionally, in the whole sample, DIF was positively associated with HCC. 
Importantly, the association between alexithymia and HCC was independent from 
depressive symptoms. This is in line with the ’alexithymia-stress -hypothesis’ 
(Martin & Pihl 1985), arguing that the decreased emotional awareness in 
alexithymics may in itself contribute to chronic physiological stress. In previous 
studies alexithymia has been associated with altered HPA-axis activity in the context 
of acute social stress (de Timary et al. 2008; Hua et al. 2014). Other studies have 
shown altered immune activity and increased inflammation in alexithymia 
(Honkalampi et al. 2011; Honkalampi et al. 2014), possibly also indicating 
physiological consequences of chronic stress.  
As discussed in section 2.7 and 2.8, alexithymia is transdiagnostically associated 
with impaired physical and mental health. Many of the diseases and disorders that 
are more common in those with alexithymia are considered at least partially related 
to chronic stress, such as depression, substance abuse, obesity and cardiovascular 
disease (Hammen 2005; Dimsdale 2008; Sinha & Jastreboff 2013). Therefore, 
chronic stress due to impaired emotional processing is a plausible candidate 
explaining the associations between alexithymia and health problems. However, as 
our study sample consisted exclusively of pregnant women, and pregnancy itself 
likely affects cortisol levels (Mustonen et al. 2018), the results need to be replicated 
in more diverse populations.  
Our previous findings show that alexithymia dimensions differentially affect 
mental health outcomes. We have hypothesized that DIF/DDF may predispose to 
internalizing problems such as depression and anxiety, whereas EOT may predispose 
to externalizing problems such as substance abuse and overeating. Therefore, we 
expected all alexithymia dimensions to be related to increased HCC, despite of their 
differential associations with health outcomes. Interestingly, only the DIF dimension 
showed an association with HCC. This might be explained by the fact highly 
alexithymic women tend to generally score higher in DIF, whereas men score higher 
in EOT. Another explanation is that if EOT is associated with chronic stress, it may 
be mediated by substance use, which in our sample was negligible due to pregnancy. 
This is another reason why it is important to replicate the findings in more diverse 
samples including men. 
The association between HCC levels and alexithymia specifically in pregnant 
women is important because it may have transgenerational effects for offspring 
health. Circulating maternal glucocorticoids can at least partially pass the placenta 
and they play crucial roles in normal fetal development. However, excessive 
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exposure to glucocorticoids, e.g. due to maternal stress or external glucocorticoid 
treatment, may harmfully affect the fetus and have long-term adverse effects for 
brain development (Seckl & Holmes 2007; Charil et al. 2010). Animal models 
suggest that prenatal stress or glucocorticoid treatment induces permanent changes 
in the offspring, increasing the risk for neurodevelopmental disorders (Seckl & 
Holmes 2007). Human studies similarly show that both prenatal stress and 
glucocorticoid levels in pregnant mothers can affect later socioemotional functioning 
and brain structure of the child (Buss et al. 2012; Madigan et al. 2018). Therefore, 
theoretically, alexithymia could be transferred intergenerationally via maternal 
prenatal stress. However, this possibility remains speculative, and future research 
will need to address possible effects of maternal alexithymia for fetal and child 
development. 
6.5 Alexithymia, Depression, Adult Attachment and 
Early-life Adversities (Study V) 
We found that alexithymia was specifically associated with childhood experiences 
of emotional neglect, whereas depression was more broadly connected to several 
types of early-life adversity. Our findings clarify the overlap and differences between 
depression and alexithymia and suggest partly different recollections of childhood 
experiences underlying these two conditions. Experience of childhood emotional 
neglect increased the prevalence of alexithymia nearly fourfold, and the majority of 
participants with high alexithymia reported experience of emotional neglect. 
Previous studies have consistently found an association between alexithymia and 
CM, particularly emotional neglect (Aust et al. 2013; Brown et al. 2016). Our 
findings add support to this evidence, and further show that the relationship between 
alexithymia and CM may be specifically explained by emotional neglect, as no other 
type of CM increased the prevalence of alexithymia. Brown et al. (2016) recently 
reported similar findings, showing that all forms of CM were associated with 
alexithymia, but in the path analyses, emotional neglect was the only form of CM 
uniquely contributing to alexithymia. They argued that emotional forms of CM may 
particularly disturb the development of affect regulation. 
Lyvers et al. (2019) have studied alexithymia in the context of alcohol abuse and 
have proposed that alexithymia may result from problematic parental bonding in 
childhood, leading to an insecure attachment style and deficient emotion regulation 
in adulthood. Our findings suggest that both attachment anxiety and avoidance are 
related to alexithymia, but attachment avoidance was more closely associated with 
it. Attachment theories hold that children may develop an avoidant style of 
attachment if caregivers habitually dismiss their emotional needs (Miculincer & 
Shaver 2012; O’Loughlin et al. 2018). Avoidantly attached individuals rely on self-
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sufficiency and independence and show a decreased tendency to seek social support 
in distressing situations (Mikulincer & Shaver 2019). Our results on the specificity 
of emotional neglect in predicting alexithymia fit this theory well, supporting the 
view that emotional neglect in childhood may lead to attachment problems and 
alexithymia. However, as we only measured attachment style in adulthood, and 
could not directly assess childhood attachment, reverse causality cannot be ruled out. 
It is also possible that alexithymia itself may predispose to interpersonal problems 
and attachment insecurity. 
Regarding the overlap and differences between alexithymia and depression, we 
found that only a minority of depressed individuals were highly alexithymic. 
Depression with concurrent alexithymia was associated with remarkably high levels 
of emotional neglect and attachment avoidance. This suggests that alexithymic 
depression may a specific subtype, arising from certain types of childhood 
experiences and attachment problems. Recently, the idea of ecophenotypes of 
depression has been put forward (Teicher et al. 2013). Evidence implies that 
depression with a history of self-reported CM may be by nature different compared 
to depression without adverse childhood experiences. The maltreated ecophenotype 
of depression has been associated with aberrant brain structure and function in limbic 
areas, as well as diminished responses to antidepressant treatment (Teicher et al. 
2013; Williams et al. 2016; Opel et al. 2019). We hypothesize that depression with 
concurrent alexithymia may similarly represent a subtype of depression that is more 
closely related to adverse childhood experiences and attachment insecurity. 
Interestingly and similarly to depression with childhood maltreatment, alexithymic 
depression may also be associated with poorer responses to antidepressants (Ozsahin 
et al. 2003). Therefore, patients suffering from depression with concurrent 
alexithymia may benefit more from psychosocial treatments focusing specifically on 
early emotional neglect and attachment insecurity. 
Some gender differences were observed in terms of CM prevalence and 
psychopathology. Women reported more emotional and sexual abuse compared to 
men. Prevalences of other types of CM showed no gender differences. Emotional 
and physical neglect were the most common types of CM, and emotional neglect 
was strongly associated with both depression and alexithymia. This is an important 
finding as many studies exploring the effects of CM have not included childhood 
neglect (Stoltenborgh et al. 2013). Regarding gender differences in depression, 
depressed men had higher levels of alexithymia and attachment avoidance compared 
to depressed women. Furthermore, emotional neglect was a unique predictor of both 
depression and alexithymia in men. This implies that emotional neglect and 
alexithymia may be particularly relevant in men’s depression. This difference may 
be explained by cultural factors, as several researchers have argued that the higher 
prevalence of alexithymia in men could be due to cultural influences that discourage 
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the expression of emotion in boys and young men (Le et al. 2002; Levant et al. 2009). 
Therefore, an emotionally distant family environment may enhance these cultural 
influences and hinder the development of emotional awareness and expression in 
men particularly. 
6.6 Limitations 
This study has several limitations that should be addressed. Firstly, the prevalence 
of alexithymia in our sample was relatively low compared to estimates from the 
general population. We conducted attrition analyses for study I and found that the 
low prevalence of alexithymia is likely due to non-random attrition. That is, 
participants who dropped out of the study before the 6-month timepoint where we 
administered the alexithymia questionnaire, had lower education, were more likely 
to be men, and had higher depressive scores, all of which are also associated with 
alexithymia levels. Sample selection bias may also partly explain the low prevalence 
of alexithymia in our cohort. As alexithymia is associated with interpersonal 
problems especially in intimate relationships, it might be that this trait is 
underrepresented in a population having a baby. 
Secondly, even though many outcomes were assessed during the women’s 
pregnancy (hair-cortisol concentrations, substance use, BMI and gestational 
diabetes), alexithymia levels in our sample were assessed 6 months after giving birth. 
In theory, this might distort some associations between alexithymia levels and 
outcomes. However, even though alexithymia seems to have both state and trait 
components, it has been shown to be a highly stable across time (Saarijärvi et al. 
2006; Hiirola et al. 2017). One study has also shown high stability in alexithymia 
levels across the perinatal period (Le et al. 2007). 
Another potential limitation is our use of self-report questionnaires. The 
problems of measuring alexithymia by self-report questionnaires are discussed in 
section 2.3. However, the TAS-20 is considered to have good validity and reliability 
in measuring alexithymia and is widely used. Self-report measures early-life 
adversity have also been recently criticized (Colman et al. 2016; Baldwin et al. 
2019), as they are subject to recall bias and correlate poorly with objective measures. 
Nonetheless, they are widely used in childhood maltreatment research, and recent 
studies have shown that self-report measures of CM predict abnormalities in brain 
structure and functions in the limbic areas, independent of psychiatric 
symptomatology (e.g. Teicher & Samson 2013; Opel et al. 2019). This strongly 
supports their value in psychopathology research. Self-report measures of substance 
abuse are also likely subject to underreporting, especially during pregnancy (Ernhart 
et al. 1988). Despite of this, they are considered sufficiently reliable and are widely 
used (Poikolainen et al. 2002). Information on pre-pregnancy weight was also based 
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on self-report, although drawn from the National Birth Registers. However, height 
was measured, and pre-pregnancy weight inquired at a doctor’s visit in gestational 
week 12. Therefore, significant errors concerning information on BMI are unlikely. 
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7 Conclusions 
As expected from previous research on alexithymia subtypes, we found that different 
dimensions of alexithymia showed differential associations with mental and physical 
health, physiological stress as well as early-life adversity. These findings underscore 
the need to treat alexithymia as a multidimensional phenomenon, with its individual 
facets having unique impacts on mental and physical health. The findings also imply 
that although many alexithymic individuals may not suffer from depressive or 
anxiety symptoms, they may still be at an increased risk for other medical problems 
such as substance abuse, metabolic problems or chronic physiological stress. This 
vulnerability may be due to problems in emotion regulation that are at least partially 
independent of psychiatric symptoms, but this remains a topic for future studies to 
address. The specificity of self-reported emotional neglect in predicting alexithymic 
traits illuminates the possible origins of this condition and its relationship with 
depression. Psychosocial treatment efforts directly addressing childhood experiences 
of emotional neglect and attachment insecurity should be investigated in the context 
of alexithymia. 
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